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Identification Of Novel Molecular-Genetic Pathways Regulating The Development
Of Subpallial Derivatives
Abstract
The embryonic subpallium produces many different neuronal cell types present throughout the adult
telencephalon, including striatal medium spiny neurons (MSN) and cortical interneurons. Dysfunction of
either cell type leads to neurological and psychiatric disorders including schizophrenia, epilepsy, and
Tourette’s syndrome. Thus, understanding the molecular pathways that regulate their development and
function has important implications for understanding disease pathogenesis. This work describes novel
methods and genetic factors that expand our ability to characterize the development and function of two
major subpallial derivatives: cortical interneurons and striatal MSN. The first part of this thesis
characterizes a novel enrichment method for producing parvalbumin-expressing (PV) interneurons from
mouse embryonic stem cells. This method, which uses an atypical protein kinase C inhibitor to enhance
intermediate neurogenesis, results in a markedly increased ratio of PV+ to somatostatin-expressing
interneurons. The findings suggest that the mode of neurogenesis influences cortical interneuron fate
determination. Moreover, PV+ interneurons can now be generated in large numbers to study their
development, screen for factors that affect their physiology, and used in therapeutic applications. The
second part of this thesis examines the function of two putative transcription factors, Zswim5 and
Zswim6, in the regulation of striatal development. We show that these genes are expressed in subpallial
precursors, and in the case of Zswim6, expressed in the adult striatum. Next, through the generation of
Zswim5 and Zswim6 knockout mice, we provide a detailed anatomical, molecular, and behavioral
characterization of the resulting phenotypes. Our findings reveal that loss of Zswim6 causes a reduction
in striatal volume and morphological changes in MSN. Additionally, these structural changes are
associated with alterations in motor behaviors including hyperactivity, impaired rotarod performance, and
hyperresponsiveness to amphetamine. These results demonstrate that Zswim6 is indispensable for
normal brain development and support findings in human genome-wide association studies that implicate
Zswim6 with schizophrenia. Collectively, this dissertation provides novel insights into telencephalic
development through the development of in vitro stem cell systems and in vivo disease mouse models
that further our ability to test and understand neurological diseases.
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ABSTRACT

IDENTIFICATION OF NOVEL MOLECULAR-GENETIC PATHWAYS
REGULATING THE DEVELOPMENT OF SUBPALLIAL
DERIVATIVES
David Tischfield
Dr. Stewart Anderson

The embryonic subpallium produces many different neuronal cell types present
throughout the adult telencephalon, including striatal medium spiny neurons
(MSN) and cortical interneurons. Dysfunction of either cell type leads to
neurological and psychiatric disorders including schizophrenia, epilepsy, and
Tourette’s syndrome. Thus, understanding the molecular pathways that regulate
their development and function has important implications for understanding
disease pathogenesis. This work describes novel methods and genetic factors
that expand our ability to characterize the development and function of two major
subpallial derivatives: cortical interneurons and striatal MSN. The first part of this
thesis characterizes a novel enrichment method for producing parvalbuminexpressing (PV) interneurons from mouse embryonic stem cells. This method,
which uses an atypical protein kinase C inhibitor to enhance intermediate
neurogenesis, results in a markedly increased ratio of PV+ to somatostatin-

v

expressing interneurons. The findings suggest that the mode of neurogenesis
influences cortical interneuron fate determination. Moreover, PV + interneurons
can now be generated in large numbers to study their development, screen for
factors that affect their physiology, and used in therapeutic applications. The
second part of this thesis examines the function of two putative transcription
factors, Zswim5 and Zswim6, in the regulation of striatal development. We show
that these genes are expressed in subpallial precursors, and in the case of
Zswim6, expressed in the adult striatum. Next, through the generation of Zswim5
and Zswim6 knockout mice, we provide a detailed anatomical, molecular, and
behavioral characterization of the resulting phenotypes. Our findings reveal that
loss of Zswim6 causes a reduction in striatal volume and morphological changes
in MSN. Additionally, these structural changes are associated with alterations in
motor behaviors including hyperactivity, impaired rotarod performance, and
hyperresponsiveness to amphetamine. These results demonstrate that Zswim6 is
indispensable for normal brain development and support findings in human
genome-wide association studies that implicate Zswim6 with schizophrenia.
Collectively,

this dissertation provides novel insights

into

telencephalic

development through the development of in vitro stem cell systems and in vivo
disease mouse models that further our ability to test and understand neurological
diseases.
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CHAPTER 1
Introduction: Structure, Function, Development,
Interneurons, and Diseases of the Telencephalon

1.1 Structure and Function of the Telencephalon
The mature mammalian telencephalon contains of hundreds of distinct neuronal
subtypes that are generated from a thin sheet of neuroepithelium during early
embryonic development. A major challenge in developmental biology is to
understand how early patterning events give rise to different progenitor domains,
and how these domains subsequently generate a seemingly endless array of
neuronal subtypes that eventually coalesce into functional circuitry that refines
and modulates itself with experience. While we have made great progress in
identifying genes and molecular pathways that control broad aspects of
telencephalic development, we are much further from understanding how
multiple, more subtle genetic perturbations that act during embryonic and early
1

postnatal periods result in the manifestation of more common, complex genetic
disorders much later in life. In order to do so, we must first understand how the
telencephalon develops on a very fine level and incorporate that knowledge into
an understanding of how its mature components interact with each other to
produce normal brain function. This introduction will attempt to lay the foundation
for my dissertation research, which uses multiple, seemingly disparate
approaches to gain insight into one of the world’s most complicated systems. To
this end, I begin broadly and introduce the telencephalon as it exists in all
vertebrates, as a structure consisting of two main territories, the pallium and
subpallium, which develop from the anterior end of the neural plate during the
first trimester of human existence.
Structure and Function of the Pallium
The pallium consists of the cerebral cortex and the subpallium contains the basal
ganglia (BG), parts of the amygdala, and septum. The most evolutionarily
advanced region of the cerebral cortex is the neocortex, which is responsible for
higher order cognitive processes such as sensory perception and control of
voluntary movement2 3. On a structural level, the neocortex is organized along
two main axes: tangentially into specialized areas with distinct function,
connectivity, and cytoarchitecture; and radially into six cellular layers, which can
be distinguished from one another based on their morphology, cell types, and
connectivity4. Within the neocortex there are two main classes of neurons:
excitatory glutamatergic neurons (~80%, pyramidal and spiny stellate neurons)
2

and inhibitory GABAergic interneurons (~20%). Glutamate is the major excitatory
neurotransmitter and GABA is the main inhibitory neurotransmitter in the
mammalian neocortex, and changes in glutamate and GABA metabolism
determine cortical excitability5. Whereas glutamatergic neurons form long-range
excitatory synaptic connections both within the cortex and outside of it, cortical
interneurons are locally projecting and have the potential to modulate large
numbers of excitatory cells within their vicinity. Both populations are organized
into vertically oriented columns and together they serve to regulate cortical
excitability6 5.
Structure and Function of the Subpallium
The subpallium, or ventral telencephalon, contains the BG, which are a collection
of nuclei that include the dorsal striatum (caudate nucleus and putamen), ventral
striatum (nucleus accumbens and olfactory tubercle), globus pallidus, ventral
pallidum, substantia nigra (SNr), and subthalamic nucleus. While most of these
nuclei project exclusively to other nuclei within the BG, many are interconnected
with various parts of the brain including the cerebral cortex, thalamus, and
brainstem7. The main output nuclei of the BG are the globus pallidus internal
segment (GPi) and the subtantia nigra pars reticulata (SNr). The main input
nucleus is the striatum; however the subthalamic nucleus also receives direct
input from the cerebral cortex8. Each nucleus has its own complex internal
anatomical and neurochemical organization and will not be discussed at length.
Together, the BG help control a variety of functions including voluntary
3

movement, procedural learning, habit formation, cognition, and emotion7.
Structure and Function of the Striatum
The human striatum is comprised of two functionally similar nuclei, the caudate
and the putamen, which are separated by the internal capsule. In mouse, these
nuclei are fused in what is commonly referred to as the caudate-putamen. The
striatum receives excitatory inputs from many different cortical areas and
thalamic nuclei9,10. Different cortical areas project to distinct regions of the
striatum, forming parallel circuits that process specific functions (Figure 1.1).

Figure 1.1. Schematic of basal ganglia circuitry.
(A). BG target structures are shown in gray. Modified from Utter and Basso (2008).
(B). Summary of the known excitatory inputs to the different striatal subdomains,
including the dorsomedial striatum (DMS), dorsolateral striatum (DLS), and nucleus
accumbens (NAc). The entire striatum receives innervation from dopaminergic (DA)
and serotonergic (5-HT) inputs. Modified from Fuccillo (2016). Abbreviations: GPe,
globus pallidus external segment; GPi, globus pallidus internal segment; SC, superior
colliculus; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulate;
STN, subthalamic nucleus; DA, dopamine; D1, dopamine D1 receptor subtype; D2,
dopamine D2 receptor subtype; Glu, glutatmate; ENK, enkephalin; SP, substance P.

4

Importantly, the striatum also contains dense innervation from midbrain
dopamine neurons, which represents a major site of synaptic plasticity11. The
striatum is unique in that it completely lacks excitatory neurons. Instead, the
striatum contains two main populations of GABAergic neurons: medium spiny
projection neurons (MSN) and interneurons, which comprise approximately 95%
and 5% of the overall population, respectively12. Information flow within the
striatum is parceled into two main streams: the direct and indirect pathways,
which act in opposing ways to control movement. The direct pathway circuit
originates from striatalnigral MSN, which receive excitatory glutamatergic input
from sensorimotor cortex and thalamus and project to GABAergic neurons in the
GPi and SNr. Striatonigral MSN are identified by their high expression of
dopamine D1 and muscarinic M4 receptors12,13. The indirect pathway circuit
originates from striatopallidal MSN, which receive input from the cortex and
project to GABAergic neurons in the globus pallidus external segment (GPe).
These neurons are identified by their high expression of dopamine D2 and
adenosine 2A receptors12. Historically, the striatum has also been divided into
striatal patch (or striosomal) and matrix compartments, which are defined by their
specific neurochemical markers and connectivity14. The patch compartment is
characterized

by

areas

of

dense

alpha-opiate

receptor

binding,

low

acetylcholinesterase labeling, and projections to dopaminergic cells of the
substantia nigra pars compacta and islands in the pars reticulata15,16. Matrix
neurons are identified by their expression of the calcium-binding protein calbindin
5

and dense innervation of SST fibers14-16. This compartment primarily projects to
the substantia nigra pars reticulata14,15. In addition, studies using retrograde
tracers have also revealed that patch and matrix compartments are differentially
targeted by corticostriatal neurons from different cortical layers and by
dopaminergic neurons from the ventral tegmental area and substantia nigra 17,18.
Together, these circuits regulate multiple aspects of human behavior, and
dysfunction in any number of them may result in a wide spectrum of neurological
and psychiatric disease.
1.2 Development of the Telencephalon
Early Patterning of the Neuraxis
Telencephalic development is regulated by multiple intrinsic genetic programs
that are shaped by secreted factors, or morphogens. The process begins with the
neural plate, a flat sheet of ectodermal cells (also known as neuroepithelium) that
evaginates and fuses dorsally to form the neural tube. Across its full extent, the
neural tube contains multipotent neural stem cells that generate both neurons
and glia of the central nervous system (CNS). Wnt proteins, fibroblast growth
factors (FGFs) and retinoic acid are expressed from the caudal end of the neural
plate and function to induce posterior character. Antagonists of these factors,
such as cerberus and dickkopf, are secreted from the anterior visceral endoderm
and act to stabilize anterior character19. Subsequently, three primary vesicles
develop in the rostral portion of the neural tube: the prosencephalon (forebrain),
6

mesencephalon (midbrain) and rhombencephalon (hindbrain). The caudal neural
tube remains undifferentiated and eventually gives rise to the spinal cord. The
prosencephalon

then forms secondary vesicles that give

rise to the

telencephalon and diencephalon (thalamus and hypothalamus), a process largely
controlled by the secreted Wnt antagonist Tlc20.
Early Patterning of the Telencephalon
FGFs serve as organizing factors in telencephalic patterning as soon as
neurectoderm first separates from ectoderm21,22. Within the anterior neural ridge
(ANR), cells begin to express FGF8, which acts as an organizer to pattern the
emerging telencephalon23 Adjacent to the ANR, the anterior neural plate
expresses the transcription factor Foxg124. Foxg1 and FGF8 form a positive
feedback loop which promotes the induction and maintenance of telencephalic
character22,25.

Dorsal-ventral

(D-V)

patterning

of

the

telencephalon

is

predominantly controlled by the dorsalizing effects of Gli3 and the ventralizing
influence of sonic hedgehog (Shh)26,27. Sonic hedgehog is expressed from the
notochord and serves to restrict genes instructive for dorsal fates. Together with
Foxg1, Shh establishes the ventral telencephalon. As the telencephalon
continues to grow, Wnt and FGF signaling becomes more specialized, and
together with bone morphogenetic proteins (BMPs), these factors specify the
dorsal telencephalic domain28,29. Downstream of these secreted morphogens,
several

key

transcription

factors

delineate

the

different

telencephalic

subdomains. Within the ventral telencephalon, FGF and Shh signaling activate
7

the expression of Nkx2.1, a homeodomain (HD) transcription factor that defines
the medial ganglionic eminence (MGE)21,22,30. As Nkx2.1 upregulates, the
homeobox transcription factor Pax6, which is initially expressed throughout the
telencephalon, downregulates in the ventral telencephalon and forms a sharp
boundary with Nkx2.1 that demarcates the D-V border. Slightly later in
development, the Pax6- and Nkx2.1-expressing regions become separated by a
domain of Gsx2 expression, which specifies the lateral ganglionic eminence
(LGE). The MGE will eventually give rise to interneurons in many forebrain areas,
including the cortex. The LGE primarily gives rise to MSN, but a region in the
dorsal domain that co-expresses Gsx2 and Pax6, has been shown to give rise to
olfactory bulb interneurons (Figure 1.2). However briefly, the dorsal cortex is also
established by gradients of transcription factors that upregulate in response to
signaling molecules and morphogens expressed from localized patterning
centers. Of these transcription factors, Pax6, Sp8, Emx2, and COUP-TFI play
integral roles in cortical area patterning31. A more detailed description of the
transcriptional programs regulating subpallial development is provided in the
sections to come.

8

Figure 1.2. Early patterning and transcriptional regulation of the telencephalon.
(A). Dorsal (top) and ventral (bottom) subdivisions of the mouse telencephalon at E9.
Shh is expressed from the ventral domain and antagonizes the dorsalizing effects of
Gli3 . Foxg1 and FGF are expressed from the anterior plate cells and form a positive
feedback loop with Shh to specify ventral character and inhibit BMP/Wnt signaling.
(B). By E10, the dorsal-most domain is split into BMP/Wnt expressing regions that
are adjacent to countergradients of the transcription factors Emx2 and Pax6.
Meanwhile, the ventral domain has been split into overlapping Nkx2.1 and
Gsh2/Gsx2-expressing regions. (C). Shown in blue are the factors responsible for
broadly establishing the early telencephalic domains and their antagonistic/agonistic
actions. Downstream transcription factors, such as Gsh2/Gsx2 and Nkx2.1 then
further subdivide the telencephalon. In the dorsal telencephalon, Gli3 promotes the
expression of BMP and Wnt proteins, which are required for EMX1/2 expression.
EMX1/2, together with Pax6 and Lhx2, further subdivide the dorsal telencephalon.
Modified from Hébert and Fishell (2008).
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1.3 Molecular-Genetic Controls over Subpallial Development
Overview
The subpallium is an exemplary case of telencephalic complexity given the
diversity of neuronal subtypes that it generates. These neurons go on to form the
BG, parts of the amygdala and septum, and as will be discussed in the following
sections, an almost endless array of cortical interneurons. However, the scope of
the work presented in this dissertation mainly concerns the production of cortical
interneurons and striatal derivatives. As such, the first part of this section will
outline

the

origins,

classification

schemas,

and

generation

of

cortical

interneurons. The second part of this section will touch upon the genesis of the
striatum and the molecular regulation governing the development of its principal
cell type, the medium spiny neuron.
Origins of Cortical Interneurons
Much of what we know about cortical interneuron development comes from
studies carried out in rodents, and this work will be the major focus of the
following introductory section. Recently however, key papers examining
developing human fetal tissue, developing non-human primate tissue, and
through the manipulation of human embryonic stem cells, have shown that many
of

these

developmental

programs

are

conserved

across

species 32,33.

Unsurprisingly, abnormalities in interneuron development can lead to disordered
cognition, and as such, interneuronopathies have been implicated in a variety of
10

neurological diseases including epilepsy, autism and schizophrenia34 35 36 37 38.
Unlike glutamatergic projection neurons, which originate in the dorsal
telencephalon and migrate radially along glial processes to populate the cortex,
interneurons are born in the ventral telencephalon and undergo a long tangential
migration up into the cortical plate39

40 41 42

. Numerous fate mapping studies

relying on the use of genetic labeling and transplantation assays have
demonstrated that different cortical interneuron subtypes originate from distinct
locations within the ventral telencephalon at different developmental stages 43 44-47
48 49

. During embryonic development, the ventral telencephalon can be divided

into two main regions: the ganglionic eminences and the preoptic area (PoA)/
anterior entopeduncular (AEP) domains50. The ganglionic eminences can be
further subdivided into three anatomically distinct domains termed the medial,
lateral, and caudal (CGE) ganglionic eminences. The vast majority (~90-95%) of
cortical interneurons originate within the MGE, CGE, and AEP/PoA, with a small,
somewhat controversial contribution from the LGE51

52 47

. As is the case for

glutamatergic projection neurons, most cortical interneurons are born between
embryonic day 11 (E11) and E17.5 in the mouse. Birth dating studies
demonstrate that cortical neurons develop radially in an “inside-out” fashion, such
that later-born neurons migrate past their predecessors to occupy more
superficial layers of the cortex53. Interestingly, despite their vastly different
origins, recent data suggests that interneurons and projection neurons born at
the same time occupy the same cortical layer, suggesting that the migration and
11

differentiation of these two populations is on some level coordinated 39 54 55 56 57.
Interneuron Subgroup Identification
The neocortex needs to perform multiple types of neuronal computations in a
diverse and flexible fashion. GABAergic inhibitory interneurons largely make this
possible by regulating the balance of activity, synaptic integration, synchrony,
spike dynamics and oscillations of neuronal ensembles 58. The ability of
interneurons to perform such complex and specific functions depends upon their
high degree of cellular diversity. Each interneuron subtype differs from one
another in terms of its morphological, neurochemical, and electrophysiological
properties59

60

. Perhaps as a consequence of this heterogeneity, specific

interneuron subtypes are differentially implicated in the pathobiology of various
neurological and psychiatric disorders61 62 63 64 59,65,66.
Roughly 50% of all cortical interneurons originate within the MGE and go on to
express the calcium binding protein parvalbumin (PV). PV interneurons can be
grouped into two morphological categories, either basket or chandeliers
subtypes, and have non-adapting fast-spiking electrophysiological profiles67-69.
Whereas PV basket interneurons target the cell body and proximal dendrites of
their synaptic partners, chandelier cells specifically target the axon initial
segment70

71

. PV expressing basket cells target both pyramidal cells as well as

other interneurons and are electrically coupled to other PV cells via gapjunctions72,73. This feature enables PV cells to regulate cortical network
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synchrony and coordinate oscillations. In particular, PV cells are essential for
initiating gamma oscillations, which are involved in higher order cognitive
functions and shown to be abnormal in several neuropsychiatric disorders74.
The second largest neurochemical category, comprising approximately 20% of all
cortical interneurons, expresses the neuropeptide somatostatin (SST). While in
the cortex PV and SST interneurons are absolutely non-overlapping, a small
population (~6%) of hippocampal interneurons expresses both neurochemical
markers75. SST expression in neocortex has typically been associated with
Martinotti cells, which characteristically target the apical dendrites of pyramidal
cells in layer I, where they elaborate vast arborizations that spread horizontally to
neighboring columns.

SST interneurons display heterogeneous morphologies

and have non-fast spiking, accommodating electrophysiological profiles76

77 68,78-

80

. About a third of SST interneurons in frontal, somatosensory, and visual cortex

co-label with calretinin (CR) and are morphologically and electrophysiologically
distinct from the SST+/CR- subgroup81. Another type of SST-expressing cell,
termed the X94 cell after the transgenic mouse from which it was first described,
are located in layers IV and V and have axonal projections that profusely
innervate layer IV77.
The remaining 30% of cortical interneurons that do not express PV or SST
express the 5HT3a receptor. This group of cells is especially heterogeneous and
remains to be fully characterized, but contains CR, reelin, and vasoactive
intestinal peptide (VIP) expressing subtypes82
13

83

. VIP interneurons account for

40% of the 5HT3aR population in S1 and are particularly enriched in layers II/III.
There appear to be several types of VIP interneurons, including neurons with
bipolar, bitufted, and multipolar morphologies that express different markers (e.g.
CCK and type 1 cannabinoid receptors) and exhibit diverse electrophysiological
properties. CR cells have bipolar or double bouquet morphologies and tend to
exhibit rapidly adapting firing patterns, while reelin-expressing neurogliaform cells
display late-spiking firing patterns. Lastly, subsets of multipolar interneurons that
express

neuropeptide-Y

(NPY)

electrophysiological characteristics84

have

rapidly

adapting

or

irregular

85

. Taken together, the MGE produces the

bulk of PV and SST-expressing subtypes, while the CGE gives rise to mostly
5HT3aR-expressing cells.
The aforementioned identification scheme is based on decade’s worth of
morphological, molecular, physiological and developmental data that has often
complicated, rather than simplified efforts to classify cortical interneurons. In fact,
estimates for the number of cortical interneuron subtypes have ranged from
around a dozen to upwards of several hundred86,87. To overcome this challenge,
some groups have suggested that interneurons exist as an assortment of species
that fall along a continuum86. More recently, another group has put forth the idea
that the large diversity of interneuron classes may in fact originate from only
handful of cardinal cell types that develop their unique cellular properties through
interactions with other neurons and local cues88. From a functional point of view,
this enables interneurons that share the same genetic origins to evolve
14

properties that fit their function. In a sense, interneuron complexity can be taken
as a proxy for the complexity of the cerebral cortex and the functions that it
performs. Regardless, the question remains of how and when interneuron fate is
determined. Interneurons traverse relatively long distances from their place of
origin in the subpallium to their ultimate location upon maturation as compared to
pyramidal cells, which follow ordered, and relatively simple migration
programs89,90. Either several different intrinsic complex migration and fate
determination programs are hardwired at the time of cell cycle exit or,
interneurons maintain some degree of plasticity that allows them to adapt to
environmental cues after migration to the cortex88.
Genetic Regulation of Interneuron Development
The initial evidence indicating that cortical interneurons come from the ventral
telencephalon came from observations of Dlx1/Dlx2 expression, followed by
analysis of the Dlx1/Dlx2 double mutant mice, which have a severe block in
interneuron migration that results in a 4-fold reduction in neocortical
interneurons39,91,92. Thus, the initial stages of interneuron development depend
on the proper patterning of the ventral telencephalon. This process is partly
controlled through gradients of Shh, which serve to regulate the expression of
downstream transcription factors including members of the basic helix-loop-helix
and homeodomain (HD) families. Together, these factors serve to pattern the
neural tube through their combinatorial transcriptional codes, which define
distinct progenitor pools along the D-V axis of the neural tube93. Of these, Dlx1,
15

Dlx2, Gsx1, Gsx2, and Ascl2 (also known as Mash1) are required for the
generation of all cortical interneurons94

95

. Dlx1/Dlx2 and Mash1 are required for

the generation of early- and late-born subpallial progenitors, respectively92,96,97.
Dlx1/Dlx2 also serve to repress oligodendrocyte production in favor of neuronal
fates through antagonism of Olig-2 expression39

98 99

. In contrast to Mash1,

which turns off as progenitors exit the cell cycle, Dlx1/Dlx2 stay on and operate at
several different stages of GABAergic interneuron maturation ranging from
GABAergic identity acquisition to regulating the initiation and termination of
migratory behavior.

Gsx-1 and -2 have somewhat redundant functions and

together promote an LGE regional fate, largely via cross-repression of Gsx2 and
Pax6100

101 102 103

. Together with Nkx2.1, this genetically determined map

delineates numerous progenitor pools that give rise to progeny with diverse fate
potentials.

However, it is becoming increasing clear that these factors, while

instrumental in establishing the basic layout of the ventral telencephalon, by
themselves cannot account for the tremendous diversity of neuronal subtypes
that are present in the mature forebrain. Therefore, there must be numerous, as
of yet uncharacterized transcriptional regulatory factors that act on a
combinatorial level with cardinal patterning genes to generate the neuronal
constituents of the many forebrain regions.
The MGE Gives Rise to PV and SST Cortical Interneurons
PV and SST expressing cortical interneurons are the primary cortical interneuron
subtypes focused on in this thesis work. They originate in the MGE and comprise
16

over half of all of neocortical interneurons83

104

. A number of key transcription

factors within the MGE have been identified, and while the list is not complete,
the genetic program that instructs the development of PV and SST lineages has
begun to emerge. This cascade of gene expression begins around E9 with the
transcription factor Nkx2.1, which acts as a master regulator to promote MGEderived interneuron fates over CGE-derived cell types47

105

. Within the MGE,

Nkx6.2 is expressed dorsally in a region that appears to be partially Nkx2.1
negative and is particularly important for the development of a subset of SST/CR
co-expressing cortical interneurons27,106

107

108

.

Nkx2.1 mediates neuronal

progenitor identity, regulates neuronal subtype specification, and directs neuronal
migration109.

Nkx2.1 is downregulated in migrating interneuron precursors

destined for the cortex, but expression continues postnatally in striatal
lineages110. The transcription factor Sip1 (also known as Zeb2) has been shown
to regulate Nkx2.1 levels either directly or indirectly in post-mitotic cortical
interneuron precursors111,112. Nkx2.1 is also expressed in the septum, AEP and
PoA105

45 113

. In addition to preventing the MGE domain from acquiring CGE

identity, Nkx2.1 directly activates a second transcription factor within the MGE –
Lhx6 – which is required for the proper differentiation of both PV- and SSTexpressing interneurons113. Interestingly, Lhx6 is initially expressed in both
GABAergic and cholinergic (ChAT) striatal interneuron precursors 114. However,
as development progresses, Lhx7 and Islet1 upregulate in ChAT-fated cells and
cause Lhx6 to turn off, thereby allowing Lhx7 and Islet1 to bind to and activate
17

cholinergic specific genes115. In the absence of Lhx7, cholinergic fated
interneurons switch fate and differentiate toward GABAergic interneurons of the
striatum116. Downstream of Lhx6 are a series of factors including Sox6 and
Satb1, which selectively affect both PV- and SST-expressing interneuron
differentiation117

118

. Although Sox6 is required for general PV and SST

interneuron subtype differentiation, PV expression appears more dependent than
SST on Sox6 function since perturbing Sox6 in mouse prevents cells from
expressing PV with no effect on SST expression119

120

. Together, Nkx2.1 and

Lhx6 are required for the normal development of PV and SST subgroups49 121 122.
Nkx2.1 is expressed in all MGE progenitors and Lhx6 is upregulated at, or shortly
before, cell cycle exit123 and continues to be expressed throughout adulthood35
107 124

. While many aspects of how these transcription factors function are still

being worked out, new tools, including the work presented in these thesis, have
been developed to meet this challenge.
Spatiotemporal Biases in Fate
Previous work from our lab, as well as others, has identified a spatial and
temporal bias within the MGE for PV versus SST interneuron generation108.
Transplantation assays of dorsal and ventral MGE at different time points
revealed that while a mix of fates are present in both regions, SST precursors are
enriched in early dorsal (dMGE) and PV precursors are enriched in late ventral
(vMGE) MGE104. Shh signaling is required for Nkx2.1 expression and gradations
of Shh strength within the MGE have been shown to influence PV versus SST
18

fates26,125

126

.

Blocking Shh signaling is sufficient to prevent Nkx2.1 protein

expression and can cause MGE-derived progeny to adopt a CGE-like CR+
bipolar fate126

127

. Higher levels of Shh signaling promotes the generation of

SST-expressing interneurons as compared to PV-expressing cells108.

By

exposing vMGE progenitors to exogenous Shh, PV fate can be suppressed in
favor of SST fates127. In line with these findings, the dMGE has higher levels of
Shh signaling as shown by enhanced expression of Gli1 and Gli2, despite Shh
being secreted in an overall low to high D-V gradient108. Although spatiotemporal
biases in the generation of interneuron subtypes exists within the ventral
telencephalon, a heterogeneous population of subtypes are generated within the
same regions at the same time107. This heterogeneity is paralleled by a diversity
of progenitor cells that are capable of producing both neuronal and glial cell
types, as well as those whose fate potential is more restricted 128.
Division Mode and Progenitor Subtype Influence PV and SST Fate
The following section lays the groundwork for much of our rationale to do the
work presented in this thesis, and as such, will be covered in considerable detail.
Several studies have clearly demonstrated that different modes of division seem
to be involved in the production of PV vs SST subgroups. Cyclin D1 and D2 are
regulators of cell cycle dynamics that are expressed in largely non-overlapping
niches. While both cyclins are expressed throughout the telencephalic germinal
zones, cyclin D1 is predominantly expressed in the ventricular zone (VZ) while
cyclin D2 is expressed in the subventricular zone (SVZ)129-131. The SVZ is mainly
19

comprised of intermediate progenitors, which arise from divisions of radial glia
occurring at the apical surface. Thus, cyclin D2 is both a marker of intermediate
progenitors and a regulator of their mitotic behavior131

132

. Interestingly, cyclin

D2-null mice have a specific 30–40% reduction of neocortical PV+ interneurons,
but these mice have a normal complement of SST+ interneurons131. These data
suggest that asymmetric divisions occurring at the VZ surface primarily generate
SST+ cells, whereas PV+ neurons seem to be generated through symmetric
neurogenic events yielding intermediate progenitors in the SVZ of the MGE131. A
recent study from our lab has recently used in in vivo fate mapping to
demonstrate this point133. In this study, the authors utilized in utero
electroporation to conduct in vivo fate mapping of cortical interneurons originating
from either apical progenitors or intermediate progenitors. In order to fate map
apical progenitors, the authors took advantage of the tubulin α-1 promoter
(pTα1), which labels neocortical progenitors at the apical surface that are known
to generate relatively few intermediate progenitors (herein referred to as short
neural precursors, or SNPs)134,135. Electroporation of pTα1-GFP into the MGE
revealed that SNPs primarily undergo neurogenic divisions, and therefore bypass
the intermediate progenitor phase, to produce a ~2:1 ratio of SST+:PV+
interneurons. On the other hand, electroporation with a nestin promoter-enhancer
construct, which fate maps all MGE apical progenitors and their progeny,
produced a ~2:1 ratio of PV+/SST+ interneurons, consistent with the overall ratio
of PV:SST interneurons produced within the MGE. Next the authors tested
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whether directing MGE progenitors toward either apical or intermediate
neurogenic divisions would bias their fate toward SST and PV-expressing
interneurons, respectively. Remarkably, electroporation of a dominant-negative
version of the Mastermind-like-1 protein (dnMAML), which blocks Notch signaling
and promotes cell cycle exit, greatly reduced the number of cyclin D2 expressing
intermediate progenitors and nearly doubled the ratio of SST + to PV+
interneurons produced. The reciprocal experiment, which used overexpression of
inscuteable to drive apical progenitors into basal progenitor states, resulted in a
3.5:1 ratio of PV+ to SST+ interneurons. Collectively, these results indicate that
not only is interneuron fate diversity a function of spatiotemporal localization of
progenitors within the MGE, but also of the apical-basal location of neurogenic
division.
Genetic Demarcation of the CGE
Morphologically, the CGE has no clear boundaries and exists as a fusion of the
MGE and LGE starting at the coronal level of the mid to caudal thalamus. The
CGE produces approximately one-third of all cortical interneurons. These
interneurons express 5HT3aR, predominantly display bipolar and bitufted
morphologies, and express a number of neurochemical markers including CR,
VIP, NPY, and Reelin39

52 47 48 82

. Relative to the MGE, there are few genetic

markers known to be specific to the CGE-derived lineages88.

However, the

orphan nuclear receptor, COUP-TFII, which is expressed in CGE, is involved in
the migration and specification of CGE-derived neocortical interneurons136. In
21

addition, the HD protein, Prox1, is known to be expressed in a subset of
CGE/LGE- and PoA-derived interneurons during embryonic development and
maintained in the mature cortex137 Loss of Prox1 impairs the integration of CGEderived cortical interneuron precursors into superficial layers and differentially
regulates the postnatal maturation of reelin, VIP, and VIP/calbindin expressing
subtypes138.

COUP-TFI and Mash1 are also expressed in the CGE

58

.

Interestingly, loss of COUP-TFI in SVZ progenitors and post-mitotic precursors
leads to a reduction of late-born, CGE-derived VIP and CR expressing cortical
interneurons, and a corresponding increase of early-born MGE-derived PV+
interneurons139. This loss is associated with increased expression of cyclin D2 in
the dorsal MGE, suggesting that the increase in PV+ cell number is due to an
increase the number of intermediate progenitors.

The ventral CGE also

expresses Nkx2.1, while the dorsal CGE strongly expresses Gsx2 and ER81, two
transcription factors that are required for the proper patterning of the LGE and for
the production of olfactory bulb interneurons, respectively30. However, while
Nkx6.2 and COUP-TFI/II are widely expressed within the CGE, they are not
restricted to it106 (Figure 1.3).

Ongoing efforts to identify CGE-specific

transcriptional programs will likely help determine the molecular mechanisms
underlying interneuron specification within this spatial domain.
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Figure 1.3. Origins and diversity of neocortical interneurons.
(A). Neocortical interneurons are produced by neuronal progenitors in the ventral
telencephalon. Most interneurons arise from either the CGE (pink) or MGE (yellow),
with a small contribution from the PoA (purple). A small, controversial source may
also arise from the LGE (green). (B). A number of transcription factors are
differentially expressed within the subpallium and specify the LGE, MGE, CGE, and
PoA. Whereas Dlx1/2/5/6, Gsh2 (also known as Gsx2), Mash1, and Olig1/2 are
expressed throughout the subpallial germinal zone, factors such as Nkx2.1 and
CoupTF1/2 are only expressed in the developing MGE/PoA and CGE, respectively.
Nkx6.2 and Gli1 are expressed are expressed within a narrow region located in
between the LGE and MGE. (C). Neocortical interneurons are highly diverse and
differ from one another on morphological, neurochemical, electrophysiological, and
targeting levels. Roughly 40% of neocortical interneurons are fast-spiking (FS)
parvalbumin (PV)-expressing interneurons and can be classified into basket or
chandelier subtypes. Not all chandelier subtypes, however, express PV.
Approximately 30% of cells express somatostatin (SST) and are morphologically
heterogeneous. These are typically non-FS. The remaining 30% express the
serotonin receptor 5-HT3AR and contain vasointestinal peptide (VIP)-expressing
and/or calretinin (CR)-expressing cells with bipolar or double-bouquet morphologies
and fast adapting firing (AD) patterns, as well as Reelin-expressing, late-spiking (LS),
neurogliaform cells. A small population of neocortical interneurons, some of which
overlap with SST, express NPY and display irregular or fast AD firing properties.
Modified from Sultan, Brown, and Shi (2013).

Genetic Regulation of LGE and Striatal Development
The LGE can be subdivided into dorsal and ventral domains140

141

. The dorsal

domain of the LGE (dLGE) expresses Pax6, Ngn2, Dbx1, and Er81. This region
predominantly gives rise to olfactory bulb interneurons, but may also contribute
neurons to the striatum proper and autonomic amygdaloid complex140

141 142

.

Notably, although the dLGE appears to be the primary source of olfactory bulb
interneurons, subsets of this population may also be generated within the pallium
and septum143. The ventral LGE (vLGE) expresses Gsx2, Mash1, and low levels
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of Pax6, and largely produces MSN140 142 144 145. As mentioned earlier, Dlx1/Dlx2
and Mash1 are important regulators of LGE development. Loss of Dlx1/Dlx2
results in a severe reduction of later born striatal matrix neurons, while loss of
Mash1 causes premature differentiation of VZ progenitors92,96. In Gsx2 knockout
mice, there is ectopic expression of Ngn2 in the LGE and a subsequent loss of
Mash1 and Dlx2142. However, even though early development of the LGE
appears to be compromised in Gsx2 mutants, as development proceeds, Gsx1 is
able to partially compensate for Gsx2 loss of function as evidenced by a
molecular reestablishment of the cortical-striatal boundary and slight increase in
expression of the striatal-matrix marker calbindin100,141,146. Although no
phenotype in Gsx1 mice was initially noted, it was recently shown that Gsx1, in
part through down regulation of Gsx2, directs progenitors toward a mature
neuronal fate103.
The nuclear receptor ligand retinoic acid (RA) is another important signaling
molecule implicated in the survival, proliferation, specification, and differentiation
of many neuronal and progenitor cells types during brain development101,147-151.
Beginning around E12.5, RA is produced in the LGE SVZ by the enzyme Raldh3,
where it regulates striatal neuron differentiation150,152. RA plays an important role
in initiating the expression of Gad67, an enzyme necessary for GABA synthesis,
in striatal precursors153. A recent studying examining retinoic acid receptor β
(Rarβ) knockout mice showed that these mice have a specific deficit in the
striatonigral output pathway, which primarily consists of dopamine receptor D1
25

(Drd1)-expressing MSN154. The transcription factor Nolz1, which is expressed in
late LGE progenitors and differentiating striatal precursors, has been shown to
act downstream of Gsx2 to activate the Rarβ receptor155. The development of the
striatonigral pathway has also been shown to depend on the transcription factor
Islet-1, which is expressed in progenitors and post-mitotic precursors that give
rise to the striatonigral pathway156,157. Loss of Islet-1 impacts the survival,
differentiation, and axonal targeting of striatonigral neurons156,157. Importantly,
Islet-1 functions to repress striatopallidal genetic programs within striatal
precursors in favor of striatonigral ones157. As a result, mice that lack Islet-1 are
hyperactive and have altered responses to pharmacological reagents that
stimulate the dopamine D1 receptor pathway156. The early B-Cell Factor 1 (Ebf1)
is yet another transcription factor implicated in the development of the
striatonigral pathway158-160. Ebf1 mutant mice have a reduction in striatal volume
due to increased cell death and a reduction in the number of striatonigral matrix
neurons with relative sparing of those in the patch compartment 159,160. Until
recently, relatively little was known about factors that specifically regulate
striatopallidal pathway development. However, a recent study has shown that the
transcription factor Sp9 is essential in this process161. Sp9 is expressed
downstream of Mash1 in LGE progenitors, maintained in post-mitotic
striatopallidal MSNs, and required for their generation, differentiation, and
survival161. Ctip2 (also known as Bcl11b) is another transcription factor
expressed in early post-mitotic MSN that is required for multiple aspects of
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striatal development162. In Ctip2 knockout mice, MSN do not fully differentiate, as
demonstrated by reduced expression of multiple mature MSN markers162. MSN
also aggregate into disordered clusters, which causes a severe disruption in
patch-matrix organization162. The forkhead box protein, Foxp1, is a long known
marker MSN, though its function in striatal development has not been studied
until recently163. Using conditional inactivation of Foxp1 in brain, it was shown
that Foxp1 causes a severe reduction in striatal volume, most likely through
defects in progenitor proliferation164. Foxp1 also regulates the morphology of
MSN and in Foxp1 heterozygous mice, MSN have significantly increased
excitability164,165. In sum, retinoic acid, acting in concert with transcriptional
regulators including Rarβ, Islet-1, Ebf1, Ctip2, Nolz1, Sp9, and Foxp1, has been
shown to play critical roles in multiple aspects of striatal development.
1.4 Interneuron Dysfunction in Neurological Disease
Epilepsy and Seizure Disorders
Proper function of the cerebral cortex requires a precise balance of excitation
and inhibition. While pyramidal neurons send information between cortical areas
and from the cortex to other areas of the brain, inhibitory tone from cortical
GABAergic interneurons shapes that activity through synchronized oscillations 166
167

. These two systems must work in a tightly controlled equilibrium in order to

produce

normal

brain

function

and

cognition.

Thus,

many

important

developmental and physiological mechanisms have evolved to maintain this
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critical balance. For example, GABAergic interneurons are the principal cellular
agents responsible for dampening hyperexcitability in the brain. As such, deficits
in GABAergic interneurons are implicated in the pathobiology of various seizure
disorders. Studies of animal models involving both genetic and acquired forms of
epilepsy support this notion

34

. For example, mutations in the Aristeless-related

homeobox gene (ARX) are frequently associated with epileptic encephalopathies
that present in infancy and childhood168

45 169,170 171 172

. ARX mutations are

known to cause a number of neurological diseases ranging from disorders of
neuronal migration that result in lissencephaly to mild intellectual disability 173,174.
However, despite the wide range of phenotypes that ARX mutation patients
present with, all share epilepsy as a major common symptom172. In the most
severe cases, mutations in ARX cause a syndrome known as X-linked
lissencephaly with ambiguous genitalia (XLAG) that is characterized by severe
developmental delay and intractable seizures175. Post-mortem examination of
patients’ brains revealed a nearly complete loss of cortical interneurons, which
has been replicated in studies of Arx mutant mice172,176-178. ARX expression in
mainly restricted to GABAergic neurons and loss of ARX has numerous
consequences on this population including abnormal migration and neuronal
differentiation179-181.
Dravet syndrome (DS) is another form of early infantile epileptic encephalopathy
that is thought to arise as a consequence of interneuron dysfunction. DS patients
typically present within the first year of life with multiple different seizure types
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including prolonged convulsive seizures and frequent episodes of status
epilepticus that are often treatment resistant182. DS is caused by heterozygous
mutations in the gene SCN1A, which encodes the type I voltage gated sodium
channel NAV1.1. NAV1.1 is a critical determinant of neuronal activity and
underlies action potential generation, and has been shown to be particularly
important for the function of fast-spiking PV interneurons183,184 185. A recent study
using induced pluripotent stem cells (iPSCs) derived from DS patients found that
inhibitory interneurons differentiated from iPSCs in vitro had pronounced defects
in action potential firing, whereas the excitability of glutamatergic neurons derived
from the same patient line were indistinguishable from controls186. Patients with
DS may progress normally early on in life, however they go on to develop
cognitive impairments and behavioral disturbances, including hyperactivity and
autistic-like traits that sometimes present after seizure onset. Although seizure
frequency decreases with age, many patients die from status epilepticus or from
sudden unexpected death in epilepsy (SUDEP)187. Studies from Scn1a+/- mice
have shown that GABAergic interneurons have dramatically reduced sodium
currents that result in an impaired ability to sustain high frequency action
potential firing. This causes an overall decrease in inhibitory tone that enables
the activity of excitatory pyramidal neuron ensembles to go unchecked.
The most common treatments for epilepsy are medications that act by
potentiating GABA function. These include drugs like barbiturates and
benzodiazepines, which bind to GABAA or GABAB receptors, which collectively
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cause dampening of neuronal activity through either the influx of hyperpolarizing
chloride ions (GABAA) or through more slowly acting metabotropic effects
(GABAB)34. About 20-30% of patients with epilepsy are refractory to all forms of
medical therapy and must consider other options. Surgery may be an effective
treatment option in some cases, but depends on many factors, including the site
of seizure origin. Although not clinically available yet, cell-replacement therapies
have also emerged as a promising treatment option for epilepsy188,189

190

.

Interneurons have the remarkable capacity to survive, migrate, and integrate into
host cortical circuitry post-transplantation. As such, several groups have
published proof-of-principal studies demonstrating its feasibility. For instance,
transplantation of interneuron precursors into neonatal neocortex of Kv1.1 mutant
mice was shown to significantly reduce the frequency of spontaneous
electrographic seizures191. Subsequently, multiple studies have gone on to show
that interneuron precursor transplantation into neonatal or adult neocortex or
hippocampus can ameliorate both the development of seizure activity and the
intensity of seizures already established192-194.
Schizophrenia
Interneuron dysfunction has been suspected to underlie a variety of
neurodevelopmental disorders in humans, including schizophrenia 195. Postmortem studies examining the prefrontal cortices of schizophrenic patients have
found a 40% reduction in GABAergic synapses196. Since then, follow-up studies
looking at mRNA expression levels in post-mortem brain samples has shown
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significant decreases of numerous interneuron markers including PV, SST, CR,
and NPY197. Schizophrenia is characterized by three groups of symptoms: 1)
positive symptoms, such as hallucinations and delusions, 2) negative symptoms,
including flat affect and social withdrawal, and 3) cognitive symptoms, such as
deficits in attention and working memory198,199. Rather than being due to deficits
in interneuron number, GABAergic dysfunction in schizophrenia may arise from
more-subtle alterations in inhibitory circuits at the level of specific synapses200.
Interestingly, some of the deficits observed in individuals with schizophrenia are
similar to those observed in patients with bipolar disorder, suggesting that a
common underlying disease mechanism may exist across these disorders201.
Numerous mechanisms may be responsible for the disruption of inhibitory
function detected in schizophrenia, all of which converge upon PV + interneurons
as central features in this disorder. Specifically, PV+ interneurons have lower
levels of GAD67 expression in patient brains, and prefrontal cortex gamma
oscillations are impaired in schizophrenic patients both at rest and during working
memory tasks36. Multiple genes that have been associated with schizophrenia
are also involved in PV interneuron development, including ERBB4 and
DISC1202,203 204 205 206. In mice, conditional deletion of Erbb4 in PV + interneurons
alone is able to recapitulate many phenotypes associated with schizophrenia
including decreased GAD67 mRNA levels, decreased dendritic spine density of
cortical pyramidal neurons, alterations in cortical excitation, and a net increase in
baseline gamma oscillations207. These results, together with studies of human
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post-mortem brain tissue, strongly implicate that GABAergic deficits may be
specific to PV interneurons and that schizophrenia susceptibility genes play a
role in the development of PV interneuron subtypes. However, a growing body of
literature continues to suggest that subtle changes in the excitatory-inhibitory
balance may be a common theme across a range of neuropsychiatric disorders
including Tourette syndrome, autism, and anxiety disorders167

196 208 209,210

.

Given that different subclasses of interneurons contribute to the generation and
pacing of distinct forms of neuronal activity via their unique targeting properties,
the functional effects of abnormal GABAergic inhibition likely depend on which
subtype of interneuron is involved. As such, it is important to gain an
understanding of the different genetic programs that contribute to the
development of distinct neuronal subtypes, since perturbations to any one of
these programs could contribute differentially to the spectrum of neuropsychiatric
disease.
Autism
In contrast to schizophrenia, which appears to involve remarkable cellular
specificity, autism spectrum disorders (ASDs) such as Rett’s syndrome might
have a more-generalized disruption of cortical excitation and inhibition167. Rett’s
syndrome is characterized by impaired language skills, cognitive deficits,
stereotypic behaviors and respiratory problems211. In more than 90% of cases,
Rett's syndrome is caused by loss-of-function mutations in the gene MECP2,
which binds methylated DNA and functions as a transcriptional repressor212.
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When MECP2 function is perturbed, inhibitory neurons contain reduced levels of
GABA, and this deficiency is thought to underlie the disease phenotype38. In
fact, loss of MECP2 function solely in mouse forebrain GABAergic neurons is
sufficient to recapitulate most of the features of Rett’s syndrome, including
repetitive behaviors, increased sociability, cognitive deficits, impaired motor
coordination, and cortical hyperexcitability167

38

. MECP2 functionally interacts

with BDNF, which plays a key role in the development and maturation of
inhibitory circuits213. Further evidence linking GABAergic deficits with the
pathophysiology of ASD and related disabilities comes from studies linking genes
encoding proteins of the neuroligin–neurexin complex with susceptibility to
autism or Asperger's syndrome214,215 216 217. On the contrary, excessive inhibition
within specific neural circuits may also be pathological as is found in Down's
syndrome167. Down’s syndrome, which is caused by trisomy of chromosome 21,
is characterized by distinct facial features, intellectual disability, and deficits in
cognitive processes that involve hippocampal function218.

Some of these

deficits, such as those that deal with spatial memory, have been replicated in a
mouse model of Down's syndrome, and the underlying mechanism seems to
involve excessive inhibition in the hippocampal dentate gyrus219-221.
In sum, a large body of literature directly implicates GABAergic dysfunction in the
pathogenesis of numerous neurological and psychiatric diseases. Since
heterogeneity in interneuron function is key in modulating cortical circuit activity,
perturbations to particular subtypes has differential contributions to human
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disease states. Further characterization of how interneuronopathies play a role in
specific disease etiologies is necessary if we wish to develop targeted, effective
treatment options. Thus, there is a growing need to understand the genetic
programs directing interneuron genesis and function, as well as for the
development of new methods to generate interneuron subtypes in vitro.
1.5 Striatal Dysfunction in Neurological Disease
Overview
The BG is a group of highly interconnected subcortical brain structures that are
conserved across vertebrate species stemming as far back as anamniotes

222,223

.

Its functions are diverse, ranging from control of movement to learning-related
motor functions, including habit formation, reinforcement learning, and motor
sequence acquisition224. A series of recurrent neural loops linking the BG with
specific input and output structures enables it to perform its numerous functions
10,11

. The BG receives excitatory synaptic input from different cortical areas, in

addition to thalamic nuclei, insula, and amygdala, which diffusely target Drd1+
and Drd2+ expressing MSN of the striatum12. MSN process these signals and
relay output to motor regions of the thalamus either directly through the SNr/GPi
or indirectly via the GPe and STN before heading to the SNr/GPi. In turn, the
thalamus, with modulation from midbrain nuclei, projects back to neocortical
areas that initially targeted the striatum, thereby providing sensory feedback
control of ongoing behavior12,223,224. Dysfunction in any of these BG nuclei can
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result in debilitating disease, and thus understanding the molecular-genetic
controls over its development and function has considerable value. The collection
of neurological disorders linked to BG dysfunction is vast, and includes Tourette
syndrome (TS), autism, obsessive compulsive disorder (OCD), schizophrenia,
dystonia, Parkinson’s, and Huntington’s disease12,223,224.
Tic Disorders and Tourette Syndrome
Although tic disorders and TS are considered separate clinical syndromes, they
are often comorbid and thought to share similar disease etiology 225. Tourette
syndrome, which affects around 1% of the population, is characterized by
sudden, repetitive, involuntary movements or vocalizations that typically begin
between 3 and 9 years of age226. Tics are generally associated with an urge or
sensation that drives the individual to perform the action, but unlike other types of
abnormal movements, they can typically be suppressed 224. The urge to perform
them, however, may be so great that in some instances they are termed
involuntary. Evidence that the BG, in particular corticostriatal circuits, is involved
in TS partly stems from observations of tics in patients with diseases that directly
affect the BG, such as Huntington disease224. Patients with TS have also been
shown to have a consistent reduction in striatal volume227,228. In support of a BG
pathophysiological basis, drugs that block dopamine or cause dopamine
depletion are highly effective at suppressing tics, whereas pro-dopaminergic
drugs exacerbate tics224. In more severe cases, deep brain stimulation of
thalamic nuclei tightly linked to the BG or different BG nuclei themselves has
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emerged as an established effective treatment option. Post-mortem evaluation of
patients with severe TS has revealed that specific interneuron populations, most
notably ChAT+ and PV+ interneurons, are reduced in both number and density in
the striatum210,229. A recent study from Xu and colleagues used targeted ablation
of ChAT interneurons in the dorsal striatum to investigate the effects of reduced
cholinergic drive on mouse behavior230. They found that a 50% reduction of
ChAT cells in the dorsolateral striatum produced behavioral manifestations of TS
including stereotypic repetitive grooming and abnormal tic-like movements after
acute stress or amphetamine treatment230. Together, multiple lines of evidence
link BG dysfunction to TS and tic disorders.
Obsessive-Compulsive Disorder
Roughly 30% of patients with TS also meet criteria for OCD, which affects
between 2 and 3% of the overall population231. OCD is characterized by recurrent
intrusive thoughts or images (obsessions) that may be followed by repetitive
compulsive behaviors224. Importantly, these repeated behaviors do not provide
pleasure or reward, but rather relieve anxiety or provide a sense of completion 224.
Like TS, OCD is believed to have a strong genetic component, but to date only a
few genetic associations have been identified232. Numerous studies, however,
point toward the involvement of cortico-striato-thalamocortical circuitry in OCD
pathogenesis233,234. Like TS, differences in striatal volume have been reported in
patients with OCD235-237and fMRI studies have shown altered activities in the
striatum, orbitofrontal cortex (OFC), and anterior cingulate (ACC) cortex during
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resting state and during the expression of symptoms238,239. OCD is most
commonly treated with selective serotonin-reuptake inhibitors (SSRI) and
cognitive behavioral therapy, and studies have shown decreased activity in the
striatum and OFC following these treatments232,240. Recently, genetic animal
models of OCD have been generated that exhibit both corticostriatal dysfunction,
as well as a common dysfunction in glutamate signaling232. For example, Sapap3
is a postsynaptic scaffolding protein highly enriched in the striatum that has been
linked to trichotillomania, a compulsive tendency to pull out ones hair241. In mice,
Sapap3

loss-of-function

causes excessive

grooming,

increased

anxiety,

abnormally high spontaneous activity of MSN, and interesting a decrease in the
number of PV+ interneurons in the dorsomedial striatum241-243. The finding of
decreased PV interneurons supports the notion that a lack of inhibitory drive in
striatal microcircuitry could cause MSN hyperexcitability and suggests that
imbalances in excitation and inhibition could contribute to OCD pathogenesis.
Furthermore, deletion of the gene Slitrk5 in mice induces a number of OCD
associated behavioral abnormalities, in addition to reduced striatal volume and
decreased MSN dendritic complexity244. Together, multiple lines of evidence from
clinical and experimental work point to the importance of the striatum and
corticostriatal pathways in the pathogenesis of OCD and obsessive compulsiverelated disorders.
Schizophrenia
The dopamine hypothesis of schizophrenia attributes the symptoms of
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schizophrenia to a dysregulation of dopaminergic signal transduction 245-247. This
hypothesis was based on observations that psychostimulates such as
amphetamine were known to exacerbate psychotic symptoms, whereas
antipsychotic medications, which primarily work by blocking dopamine receptors
or function, are highly efficacious in alleviating these symptoms 247. In particular,
striatal dopamine hyperactivity has been one of the most replicated physiological
findings in schizophrenia. For example, several post-mortem studies of
schizophrenic patients have reported an increase in subcortical dopamine and
dopamine metabolite (e.g. homo-vanillic acid) levels248. This is supported by
imaging findings showing increased synthesis of dopamine within the striatum of
schizophrenic patients245. Furthermore, an upregulation of striatal D2 receptors
has been observed in post-mortem studies of drug-naïve patients, and this has
been replicated in several PET imaging studies showing increased D2 receptor
occupancy249. Higher dopamine availability, as measured by amphetamineinduced dopamine release, has also been found on PET imaging in
schizophrenic patients, supporting the notion that increased stimulation of D2
receptors could be part of the etiology of schizophrenia 250.

Further support

comes from genetic studies, which have consistently found associations between
variations in genes involved in dopamine signaling, such as Drd2, and
schizophrenia246,251. While multiple lines of evidence support dopaminergic
hyperactivity in the striatum (mesostriatal and mesolimbic pathways), this does
not appear to generalize to all areas of the brain. MRI and PET imaging suggest
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that cortical dopamine hypofunction contributes to the cognitive symptoms in
schizophrenia252. This raises the question of whether hypodopaminergic function
in the cortex and hyperdopaminergic function in the striatum are driven by a
common disease process, or whether one drives the other. While reciprocal
connectivity between the cortex and striatum makes this determination difficult in
humans, animal models have been much more helpful. In both rats and primates,
dopamine depletion in the prefrontal cortex leads to an increase in subcortical
dopamine turnover and dopamine D2 receptor numbers253,254. On the other hand,
overexpression of dopamine D2 receptors in the mouse striatum leads to
impairment in prefrontal-dependent cognitive tasks that are associated with
schizophrenia, decreased prefrontal cortex dopamine turnover, and increased D1
receptor activation in the prefrontal cortex255-257. Interestingly, overexpression of
the D2 receptor in striatum leads to a decrease in striatal volume that is
secondary to changes in MSN morphology258. Medication-naïve schizophrenic
patients also show decreases in striatal volume as well as alterations in MSN
morphology. It has also been shown that children of schizophrenic patients have
decreased striatal volume relative to children without a family history of mental
illness, suggesting that a reduction in striatal volume might be an early event in
the development of the disease or an underlying risk trait 245. Together, multiple
lines of evidence from human clinical and post-mortem studies, as well as animal
models support a role for the striatum in the pathogenesis of schizophrenia.

39

CHAPTER 2
Atypical PKC Inhibition Enhances the Generation of
PV Cortical Interneurons from Embryonic Stem Cells

2.1 Generating GABAergic Cortical Interneurons from Mouse Embryonic
Stem Cells
Overview
Embryonic stem cells (ESCs) are a renewable resource that have the potential to
differentiate into almost any cell type within the human body. They can be used
to model human development, screen for factors that affect cellular physiology,
and used to treat human disease. However, before we can realize their full
potential, several significant barriers must be overcome. Perhaps the most
difficult challenge is to develop methods that direct the differentiation of stem
cells into specific cell types. Moreover, in order to fully utilize their potential, cells
derived in vitro through the use of ESCs must, to a large extent, be as similar to
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their in vivo counterparts as possible. This includes the expression of
neurochemical markers, morphology, and ultimately, their ability to function
equally in the same environment. From the standpoint of understanding and
treating neurological and psychiatric diseases, there is much to be gained from
being able to generate an endless supply of distinct neuronal subtypes in vitro. If
we consider interneurons, this is especially challenging given the astonishing
diversity of interneuron subtypes that exist. If we are to achieve the promise of
interneuron-based therapies for interneuron related diseases, we must be able to
produce enriched populations of particular subtypes since interneuron subtypes
are differentially affected in various disorders190,259-262. To complicate matters,
many aspects of interneuron fate are extrinsically determined through
interactions with neighboring cells, which are numerous in type and wired
together into intricate circuits that are laid down during embryonic and early
postnatal development. In order to promote their differentiation, neurons derived
in vitro are usually replated onto a layer of feeder cells (typically other neurons
and/or glia) that support their growth and provide the necessary synaptic inputs
to promote their functional maturation. Alternatively, neurons can be transplanted
into the regions of neonatal or adult brains where they are normally found. This
method is typically superior to feeder layers in terms of promoting a mature fate.
In the case of human ESC-derived interneurons, xenographic transplantation
usually elicits an immunogenic reaction. Although this problem can be overcome
with the use of immunosuppressants or immunodeficient hosts, a more
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fundamental barrier is at hand: the protracted maturation of human-ESC derived
interneurons263. Even several months post-transplantation, human ESC-derived
interneurons continue to express immature neuronal markers, suggesting that
they are following a prolonged intrinsic maturation program mimicking normal
human development264

265 266 267 263

. Fortunately, the molecular programs that

direct cortical interneuron development are largely conserved between mouse
and human, including Nkx2.1 and Lhx6 expression patterns33
post-transplant

into

mouse

neonatal

neocortex,
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. By 30 days

mESC-derived

cortical

interneurons display morphological, neurochemical, and electrophysiological
signatures characteristic of mature cortical interneurons268,269. Hence, mESCs
enable the study of interneuron development in a practical time frame and in an
accessible system, which is of great translational value. The following chapter
describes progress using an atypical protein kinase C inhibitor to enhance the
generation of PV+ interneurons from mESCs.
Generating Interneurons from mESCs
Over the past decade, many groups, including our own, have succeeded in
generating cortical interneurons from mESCs268-273. This has been achieved
largely by recapitulating in vitro using growth factors and small molecule
inhibitors the sequence of events that induce telencephalic character and ventral
patterning endogenously. As will be discussed, neural fate commitment is first
achieved through inhibition of mesoendoderm induction pathways, which are
otherwise promoted. Following neural induction, the naïve neural progenitors are
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then patterned using ventralizing factors such as Shh. Watanabe and colleagues
pioneered this field by describing a differentiation protocol to efficiently generate
telencephalic precursors from mESCs using a suspension embryoid body (EB)
method in serum-free media271. Interestingly, they showed that roughly 70% of
mESCs undergo neural conversion to Nestin+ neural progenitors after 8 days in
serum-free suspension culture followed by 2 days of adherent culture271. This
was in contrast to serum-containing media, which for reasons that are not fully
understood promotes differentiation into primitive endodermal and mesodermal
lineages274. With the addition of the Wnt and Nodal antagonists Dkk1 and LeftyA
during the first 5 days of culture, they were able to increase this to ~90%, as
shown through the use of a Sox1::GFP mESC reporter line, which identifies early
neuroectodermal cells271. Of these cells, roughly ~35% expressed the
telencephalic marker Foxg1271. This data suggests that the first 5 days of
differentiation are critical for achieving efficient telencephalic induction. Next, the
authors showed that by adding the dorsalizing factor Wnt3a and ventralizing
factor Shh, they could induce the expression of Pax6 and Nkx2.1, respectively,
within the Foxg1 population271. Approximately 5–15% of all the cells generated
were Foxg1+/Nkx2.1+, and could be regarded as ventral telencephalic-like and
~ 5–8% of the cells were Foxg1−/Nkx2.1+, probably representing a ventral
diencephalic hypothalamic precursor271. Although this study also reported the
generation of a small percentage of GABA+ neurons after 20 days in culture, they
did not characterize which subtype(s) of GABA+ neurons they represented. Our
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group built upon this early work by developing a Lhx6::GFP mESC reporter line,
which was used to generate, visualize, and isolate cortical interneuron precursors
of an MGE-like lineage268. This protocol used the BMP inhibitor noggin from
differentiation days (DD) 0 to 5 to initiate neural induction, followed by the
addition of FGF2 and IGF1 from DD5-8268. The patterning effects of FGF2 and
IGF1 were not thoroughly investigated, but are thought to increase neural
progenitor proliferation (personal communication). Shh was also added from
DD5-12 to promote ventral telencephalic character. The Lhx6::GFP+ cells were
FACS isolated and transplanted into mouse neonatal neocortex to investigate
their in vivo potential268. Analysis of these brains 30 days post-transplantation
revealed that Lhx6::GFP+ cells migrated extensively in the tangential plane away
from the injection site268. These cells expressed GABA and displayed
morphologies consistent with MGE-derived cortical interneurons268. Further
analysis showed that a majority of these cells expressed mature interneuron
markers such as PV, SST, and NPY and had electrophysiological profiles
characteristic of their in vivo counterparts268. However, only 2% of all cells
expressed Lhx6::GFP. Moreover, the protocol lacked the ability to specifically
bias their fates to one subgroup over the other268. Therefore, further protocol
optimization was necessary in order to generate higher yields of interneuron
precursors, which was subsequently accomplished in a recent publication from
our lab. In order to improve the telencephalic induction in our differentiation
paradigm, and thereby increase the fraction of cells that could go on to become
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Foxg1+/Nkx2.1+ progenitors, we took advantage of the cross-regulatory network
of Shh and Wnt signaling that is required for normal MGE development 20,29,275,276.
In this system, Wnts are strongly expressed in the dorsal and caudal domains of
the developing CNS, whereas Dkk1, an endogenous WNT inhibitor, is expressed
from the anterior visceral endoderm277. Together, Dkk1 and Wnt/β-catenin
mediate anterior-posterior axis polarization by functioning as repulsive and
attractive

guidance

cues,

respectively,

during

visceral

endoderm

cell

migration28,252,253. Therefore, in order to prevent cells from adopting caudal or
dorsal fates, we applied the small molecule WNT inhibitor XAV939 278 together
with the BMP inhibitor LDN-193189 from differentiation days (DD) 0-5 in our
previously published differentiation protocol268. Remarkably, this resulted in a
90% conversion of mESCs to a Foxg1 expressing forebrain-like fate by DD12269.
Additionally, XAV potently induced a ventral telencephalic fate in mESCs
differentiated via this paradigm as evidenced by a 20-fold increase in Foxg1 and
Nkx2.1 co-expression. the To add the capacity of isolating interneuron
progenitors to our Lhx6::GFP line, an Nkx2.1 bacterial artificial chromosome in
which mCherry expression is driven by the Nkx2.1 promoter was inserted. As
expected, nearly all DD12 FACS-isolated Nkx2.1::mCherry-expressing cells go
on to express Lhx6::GFP within 24-36 hours, and following transplantation into
neonatal neocortex, ~90% expressed the mature cortical interneuron marker
Sox6 and GABA. These results indicate that Nkx2.1::mCherry-expressing cells
are bona fide MGE-like progenitors capable of giving rise to mature cortical
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interneurons. Next, this study took advantage of the known developmental
programs that differentially bias progenitors to produce PV+ and SST+ fated
interneurons in vivo. First, a much larger percentage of all early born
interneurons are SST+ fated as compared to PV+, which are predominantly
produced at later stages45,49,127. Second, higher levels of Shh signaling in dorsal
MGE appear to bias progenitors to produce SST+ interneurons 45,49,127. Thus, by
isolating early (DD12) Lhx6::GFP+ precursors grown in the presence of high Shh,
we achieved a 6.4:1 ratio of SST +:PV+ interneurons (64% SST+, 10%PV+, 25%
PV-/SST-)269. On the contrary, by isolating late (DD17) Nkx2.1::mCherry+
progenitors grown in low Shh conditions, we achieved a ~2.9:1 ratio of PV +:SST+
interneurons (19% SST+, 56% PV+, 25% PV-/SST-). It is worth noting that in this
study, the low Shh condition indicates that no exogenous Shh was added. It was
found that after exposure to XAV, the cultures alone generated sufficient levels of
Shh to support moderate induction of Nkx2.1 and Lhx6. Around the same as this
study was published, another group published a report of using the forced
expression of lineage defining transcription factors to generate specific
subpopulations of cortical interneurons and screen for genetic factors that could
augment the differentiation and/or specificity of in vitro-derived cortical
interneurons273. The authors used the same base protocol as in Watanabe 2005
but modified their mESC line with a construct containing the nestin promoterenhancer sequence driving Nkx2.1 and a tetracycline-responsive transactivator
protein (Nkx2.1::IRES-tTA2S). Dlx2 is then driven by a tetracycline response
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element, which is bidirectional and can drive expression of a candidate gene of
choice simultaneously. To identify putative cortical interneuron precursors, the
authors also inserted a sequence containing the Dlx5/6 intergenic element to
drive eGFP expression. Cells were then sorted for Dlx5/6-eGFP, transplanted
into embryonic ventral telencephalon, and analyzed for fate in the cortex several
weeks later. The base line, whereby nestin drives Nkx2.1 and Dlx2 without a
candidate gene, resulted in the following fate enrichment: 35% PV+, 30% SST+,
25% CGE-like (reelin+ or VIP+) and 10% unlabeled. Next, the authors tested the
effects of 12 different candidate genes selected on the basis of being expressed
in cortical interneuron progenitor zones but of unknown function. Of the 12 genes
tested, LMO3 and Pou3f4 appeared to facilitate the differentiation of cINs in
different ways. Whereas Pou3f4 improved the general efficiency of mESCderived interneuron differentiation, LMO3 augmented the MGE-derived basket
cell population, resulting in the following fate enrichment: 56% PV, 21% SST,
16% CGE-like and 7% unlabeled. Importantly, this result, which was gleaned
from an in vitro mESC-system, reliably predicted the phenotype of the LMO3 null
mouse, which was then shown in the same study to have a previously
uncharacterized ~30% reduction in the number of PV+ cortical interneurons273.
While the aforementioned studies269,273 made significant progress in generating
cortical interneuron subgroups from mESCs, we hoped to build upon these
studies further by leveraging recent data from our lab indicating that the location
of neurogenic division within the MGE is a critical mechanism for determining
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interneuron fate. Thus, the work described in this chapter complements this study
and enhances our ability to generated PV+ interneurons from mESCs.
2.2 Atypical PKC inhibition Enhances the Generation of PV Cortical
Interneurons from Embryonic Stem Cells
Overview
Parvalbumin-expressing (PV) interneurons comprise close to half of cortical
interneurons and their dysfunction is implicated in neuropsychiatric disorders.
Improved methods to generate PV-interneurons from stem cells would not only
aid in the study of their development and function, but enable their use in cellbased therapies. Recent studies indicate that the location of neurogenesis within
the medial ganglionic eminence (MGE) critically influences the fate determination
of cortical interneuron subgroups, with PV interneurons originating from SVZ
divisions. Importantly, the aPKC-CBP pathway regulates the transition from
apical to basal progenitor and their differentiation into post-mitotic neurons. We
find that aPKC inhibition enhances intermediate neurogenesis from stem cell
derived MGE progenitors, resulting in a markedly increased ratio of PV to
somatostatin-expressing interneurons. These findings confirm that the mode of
neurogenesis influences the fate of MGE-derived interneurons and provide a
means to further enrich for the generation of PV-interneurons from pluripotent
stem cells.
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Introduction
Proper function of the cerebral cortex requires the coordinated activity of two
distinct neuronal populations: excitatory projection neurons and inhibitory
GABAergic interneurons (cINs). In both mice and humans, roughly half of all cINs
originate within the medial ganglionic eminence (MGE) of the subcortical
telencephalon and can be separated into two non-overlapping categories defined
by their expression of either parvalbumin (PV) or somatostatin (SST)80,88. While
SST interneurons primarily target the dendrites of their synaptic partners, PV
interneurons mainly target the cell body, proximal dendrites, or the axon initial
segment of pyramidal neurons83. Interneuron dysfunction is implicated in major
neurological and psychiatric diseases including autism, schizophrenia, and
epilepsy167.
Due to their remarkable capacity to migrate, survive, and integrate into cortical
circuitry after transplantation, cINs are attractive candidates for use in cell-based
therapies of disorders of cortical inhibition, such as epilepsy190,279. Although
progress has been made in generating enriched populations of interneuron
subgroups from pluripotent stem cells280,281, protocols to efficiently generate
highly enriched samples of PV-interneurons are lacking.
We recently used in vivo fate mapping to demonstrate that PV interneurons
originate primarily from divisions of intermediate progenitors in the SVZ of the
MGE133. In addition, we found that MGE progenitors forced to undergo SVZ
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divisions generate PV-expressing interneurons at the expense of those
expressing SST. This finding is consistent with a previous study that loss of cyclin
D2 (CCND2; CD2), which is expressed in intermediate progenitors throughout
the telencephalon, results in reduced numbers of PV interneurons without
affecting the SST-expressing subgroup130. Loss of CoupTF1, which results in
increased expression of CD2 in the dorsal region of the MGE where most SST
interneurons normally originate104, also results in supernumerary production of
PV interneurons139. Together, these findings suggest that enhancement of
intermediate progenitor-like divisions should enhance production of PV
interneurons from stem cell differentiations.
The atypical protein kinase C (aPKC)-CREB-binding protein (CBP) signaling
pathway regulates the differentiation of interneurons from ventral forebrain neural
progenitors282. Activation of aPKC results in the phosphorylation of CREB,
thereby promoting neural differentiation283. In addition, aPKC is an integral
component of the aPKC/Par complex that regulates cell polarity, division
orientation, and the localization of cell fate determinants 284. Through antagonistic
interactions with lethal giant larvae (Lgl), the aPKC/Par complex functions to
asymmetrically localize the Notch inhibitor Numb, which subsequently regulates
the proliferation and differentiation of neural progenitors285. Given the many roles
of aPKC in regulating cell polarity and fate, we examined whether aPKC
inhibition during directed differentiations of embryonic stem cells into post-mitotic
interneuron precursors will bias progenitors to undergo SVZ-like divisions. We
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find that a myristoylated PKC pseudosubstrate peptide inhibitor (aPKCi), applied
to our “MGE” protocol that enriches for Foxg1 and Nkx2.1-expressing interneuron
progenitors, significantly increases the fraction of these progenitors that express
CD2. Moreover, treatment of stem cell differentiations with aPKCi greatly
enriches for the generation of PV-expressing interneurons at the expense of
those expressing SST. Taken together, our system provides a novel platform for
further study of cortical interneuron genesis, fate determination, and for their use
in the development of cell-based therapies.
Results
Generation of Nkx2.1-expressing interneuron progenitors
Our previous study used a dual-reporter mouse embryonic stem cell (mESC) line
for the isolation of interneuron-fated cells at the progenitor and post-mitotic
stages269. This line expresses mCherry and GFP under the control of the Nkx2.1
and Lhx6 loci in bacterial artificial chromosomes, respectively. The line can be
differentiated

using

a

modified

version

of

our

previously

established

differentiation protocol (Figure 2.1 A)268,269 into a highly enriched population of
FoxG1 and Nkx2.1-expressing MGE-like progenitors. Although only ~11% of all
Nkx2.1+

cells express mCherry by differentiation day (DD) 11, nearly all

mCherry expressing cells also express Nkx2.1 protein, confirming the fidelity of
the reporter (Figure 2.1 B, C). Thus, this system serves as an excellent platform
for

studying

stem

cell

derived
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MGE-like

progenitors

in

vitro.
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Figure 2.1 aPKCi increases the proportion of CD2-expressing Nkx2.1 MGE
progenitors.
(A). Schematic of the differentiation protocol, with and without the addition of aPKCi
from DD8-DD11. (B). Representative immunostaining of Nkx2.1 and
Nkx2.1::mCherry from the JQ27 line at DD11 differentiated via the protocol shown in
Fig 1A. (C). Quantification of the percentage of Nkx2.1::mCherry cells that also
express Nkx2.1 protein, as well as the percentage of Nkx2.1+ cells that express
Nkx2.1::mCherry. Neither of these measures is affected by aPKCi treatment. (D).
CD2 with Nkx2.1::mCherry and Nkx2.1 immunofluorescence on DD11 cultures grown
with and without aPKCi from DD8-DD11. (E). Quantification of the percentage of
Nkx2.1 and Nkx2.1::mCherry-expressing cells that express CD2 shows a significant
increase in the aPKCi treated condition. *p < 0.05; ***p<0.001 (pooled data from four
independent experiments). Error bars indicate SEM. Scale bars 30 μm in B, C.

Atypical PKC inhibition increases the fraction of cyclin-D2 expressing
Nkx2.1::mCherry progenitors
We reasoned that if inhibition of aPKC biases progenitors toward intermediate
neurogenesis, treatment of differentiations with the aPKCi beginning at DD8,
when most of the cells in the culture express Nkx2.1, should increase the fraction
of Nkx2.1::mCherry progenitors that also express CD2. Indeed, aPKCi
significantly increased the percentage of CD2-expressing mCherry and Nkx2.1positive progenitors (Figure 2.1 D, E). To determine whether the effect of aPKCi
on CD2 expression by Nkx2.1+ progenitors is more broadly applicable to other
stem cell lines and clones, we differentiated several additional mESC lines using
the same protocol and found that aPKCi significantly increased the fraction of
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Nkx2.1-expressing

progenitors

that

also

express

CD2

(Figure

2.2).

Figure 2.2. aPKCi increases the proportion of CD2-expressing Nkx2.1
progenitors in two additional mESC lines.
(A). Quantification of the proportion of Nkx2.1 progenitors that co-express CD2 at
DD11. J1 (ATCC® SCRC-1010™) is the parent line of JQ27, used in this study. JQ59
is another J14 (Maroof et al 2010) subclone that also contains the Nkx2.1::mCherry
BAC. The mCherry reporter expression in this line, however, is minimal. *p<0.05; #
p<0.05 in Mann-Whitney U-test. Error bars indicate SEM.

To determine whether aPKCi treatment also influences progenitor proliferation,
we pulsed cells for 30 minutes with the modified thymidine analogue EdU, which
marks cells in S-phase, together with immunostaining for the proliferation marker
Ki-67. Analysis of both markers showed no significant change in the fraction of
EdU or Ki-67 expressing mCherry and Nkx2.1-positive progenitors with aPKCi
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treatment (Figure 2.3). Together, these results suggest that aPKCi biases
progenitors

toward

intermediate

neurogenesis

proliferation.
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without

affecting

overall

Figure 2.3. aPKCi does not affect progenitor proliferation.
(A). Representative images of EdU and Ki-67 together with Nkx2.1::mCherry or
Nkx2.1 immunofluorescence on DD11 cultures grown with and without aPKCi. (B).
aPKCi does not change affect the percentage of Nkx2.1:mCherry and Nkx2.1expressing cells that label for EdU or Ki-67. *p<0.05; **p<0.01 (pooled data from
three independent experiments). Error bars indicate SEM. Scale bars 30μm in A, B.

Atypical PKC inhibition influences the mode of neurogenesis
An additional benefit of our dual reporter mESC line is that the expression of
mCherry and GFP enables us to evaluate whether the outcome of a division is
proliferative or neurogenic. Using time lapse confocal microscopy, we found that
from DD8 to 10 in some instances an Nkx2.1::mCherry progenitor divided into
two mCherry-positive progenitors that then go on to divide again into
Nkx2.1::mCherry+ cells (Figure 2.4 A, B). Other examples include symmetrical
neurogenic divisions in which a mCherry-expressing progenitor divides to
produce two Lhx6::GFP, post-mitotic interneuron precursors, which have visibly
enhanced migratory activity (Figure 2.4 C, D). On rare occasions, more complex
division

schemes

could

be

visualized,

incorporating

both

symmetrical

proliferative, symmetrical neurogenic, and asymmetrical neurogenic divisions
(Figure 2.4 E, F).
Using this system, we hypothesized that aPKCi treatment should increase the
fraction of Nkx2.1::mCherry daughter cells that divide symmetrically to produce
two progenitors. Indeed, we found that aPKCi nearly doubled the percentage of
Nkx2.1::mCherry progenitors that were observed to undergo a second division.
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Together with the increased co-labeling of Nkx2.1-expressing progenitors with
CD2, these results suggest that aPKCi biases interneuron progenitors to undergo
SVZ-like divisions (Figure 2.4 G).

57

Figure 2.4. Live cell imaging enables analysis of cell divisions and shows that
aPKCi increases the proportion of Nkx2.1:mCherry daughter cells that undergo
a second division.
(A). A series of time-lapse images showing a single Nkx2.1:mCherry progenitor
dividing symmetrically to produce two mCherry-expressing progenitors, which then go
on to divide again during the 48 hour imaging session. Time is displayed as
(hours:minutes). (B). Lineage relationships between cells in A. (C). A series of time
lapse images showing a symmetrical neurogenic division, wherein one
Nkx2.1::mCherry progenitor divides symmetrically to produce two Lhx6::GFP
daughter cells. Merge of GFP and mCherry channels shown in dotted inset. (D).
Lineage relationships between cells in C. (E). Time lapse imaging showing a more
complex division scheme involving symmetrical proliferative, symmetrical neurogenic,
and asymmetrical neurogenic divisions. (F). Lineage relationships between cells in E.
(G). Quantification of the number of daughter cell divisions, defined by a
Nkx2.1::mCherry daughter from a previous division that goes on to divide again. The
number of daughter divisions is divided by the total number of Nkx2.1::mCherry
divisions counted. The addition of aPKCi significantly increases the percentage of
Nkx2.1::mCherry progenitors that divide again (pooled data from five independent
experiments; 95 divisions counted in –aPKCi treated condition, 84 divisions counted
in +aPKCi condition; *p < 0.05). Error bars indicate SEM. Scale bars 30μm in A, C.

Atypical PKC inhibition enhances PV fate specification
Since directing MGE progenitors to undergo SVZ divisions directs them to
produce PV-expressing cortical interneurons in vivo286, and since the aPKCi
enhances the generation of SVZ-like progenitors in vitro, we next asked whether
this treatment enhances the derivation of PV interneurons relative to SST
interneurons in our stem cell system. mCherry progenitors differentiated in the
presence or absence of aPKCi were isolated at day 11 via FACS and
transplanted into neonatal mouse neocortex (Figure 2.5 A). Following
transplantation, the mCherry reporter downregulates as the Lhx6::GFP reporter
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becomes expressed in the post-mitotic interneuron precursors and is maintained
in those cells thereafter (Figure 2.5 B)269. Thirty days post-transplantation, the
fates of transplanted cells was assayed via immunostaining for GFP,
parvalbumin (PV), and somatostatin (SST). aPKCi treated cultures resulted in a
tremendous enrichment of PV-expressing interneurons at the expense of those
expressing SST (Figure 2.5 C, D). Immunostaining for the MGE-derived cIN
marker Sox6, together with GABA, confirms that aPKCi treated cells retain the
appropriate lineage markers (Figure 2.6).
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Figure 2.5. Strategy to enhance the generation of parvalbumin (PV)-expressing
interneurons from a dual Nkx2.1:mCherry-Lhx6:GFP mouse stem cell reporter
line.
(A). Representative FACS plot of the JQ27 line (Tyson et al., 2015) at DD11 shows
segregation of mCherry-only (red), mCherry/GFP co-expressing (yellow), and GFPonly (green) expressing populations from non-fluorescent cells (black). (B).
Schematic of reporter progression in mESCs differentiated towards Nkx2.1-and Lhx6expressing fates, then subjected to FACS for mCherry on DD11, followed by
transplantation into neonatal mouse cortex. After 30 days the animals are sacrificed
and the fates of transplanted cells are assayed. (C). Quantification of SST or PV
expression in Lhx6::GFP-expressing cells differentiated in the presence or absence
of aPKCi from DD8-DD11 (-aPKCi 31.3±2.4% PV, 33.5±2.14% SST and 35.3±0.87%
double negative; +aPKCi 51.9±4.5% PV, 9.03±1.4% SST, 39.1±3.6% double
negative, SEM).The addition of aPKCi from DD8-DD11 significantly increases the
ratio of PV to SST cells generated (n=4 independent differentiations, 8 brains total;
P<0.005). (D). PV immunofluorescence on Lhx6::GFP expressing cells from the
aPKCi condition 30 days post-transplant. PV, parvalbumin; SST, somatostatin. Scale
bars 50 μm in D; 400μm in B.
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Figure 2.6. aPKCi treated cells express Sox6 and GABA.
(A). Representative brain sections containing transplanted Lhx6:GFP cells
immunostained for Sox6, GABA, and GFP, with high-magnification images of
individual cells expressing Sox6 and GABA. (B). aPKCi does not significantly change
the percentage of transplanted cells that express Sox6 or GABA (pooled data from
four independent experiments). Error bars indicate SEM. Scale bars 40μm in A;
10μm in insets.

Discussion
Cortical interneurons represent a remarkably heterogeneous population of cells
in terms of their morphology, connectivity, electrophysiology, and neurochemical
profiles. As a consequence, interneuron subtypes differentially contribute to
network processing that underlies a wide range of cortical functions. By
extension, dysfunction of distinct interneuron subtypes is implicated in the
specific pathobiology of major neurological and psychiatric diseases. Thus,
considerable effort is being put forth to generate specific interneuron subgroups
or subtypes from embryonic stem cells. The capacity to do so would not only
allow for the study of factors that regulate the type, number, or function of
interneurons, but would enable their use in cell-based therapies.
Our previous study showed that manipulations of sonic hedgehog (Shh)
exposure and time in culture differentially enrich for PV- versus SST-fated mESC
derived cINs280. While early born cells exposed to higher levels of Shh produced
a ~6.4:1 ratio of SST to PV, increased duration in culture combined with lower
levels of Shh generated a ~2.6:1 ratio of PV to SST. Another study using the
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forced expression of transcription factors in a gain-of-function approach found
that Lmo3 expression after the expression of Nkx2.1 and Dlx2 was able to
achieve a 2.7:1 ratio of PV to SST 281. In this study, we used aPKC inhibition to
achieve a ~5.8:1 ratio of PV to SST. This is to our knowledge the greatest
enrichment for PV expressing subtypes that has been obtained from mESCs todate.
Although it remains unclear how aPKCi promotes intermediate neurogenesis in
the context of our “MGE” differentiation system, there are several intriguing
possibilities. First, the atypical PKC subgroup contains two isoforms, iota (ι or λ)
and zeta (ζ), which have been shown to have numerous, distinct functions in the
regulation of cell polarity, proliferation, and neural differentiation

284,287,288

. Loss of

aPKCλ in mouse stem cells enhances self-renewal through the activation of
NOTCH1 and its downstream effectors289. Similarly, in dorsal neocortex,
knockdown of aPKCλ delays neural differentiation and expands the pool of Tbr2+
intermediate progenitors, whereas knockdown of aPKCζ promotes radial glia
self-renewal287. Taken together, these studies show that aPKC λ and ζ largely
promote stem cell differentiation through partially overlapping pathways. In our
system, we use transient, partial inhibition of both aPKC isoforms to enhance the
production of CD2+ intermediate progenitors. We favor the idea that partial
inhibition of both isoforms promotes a balance between differentiation and selfrenewal, resulting in the expansion of basal progenitors. Additional studies
focusing on the selective loss of either isoform during directed differentiations of
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stem cells into interneuron progenitors are needed to fully understand their
individual roles in interneuron genesis. Based on the result of this study, such
knowledge might have profound implications for enhancing the generation of
interneuron subtypes from directed differentiations of stem cells.
In the field of cancer biology, aPKCs have generated considerable interest due to
their roles in driving cellular proliferation. Interestingly, in basal cell carcinomas,
aPKCλ forms a complex with missing-in metastatis (MIM) that potentiates sonic
hedgehog (Shh) signaling290. Genetic or pharmacological loss of aPKCλ blocks
Shh signaling and cancer cell proliferation. Previous studies from our lab have
shown that lower levels of Shh signaling preferentially bias MGE progenitors to
PV-expressing interneuron fates127,280. It is tempting to speculate that aPKCi may
also bias progenitors to produce PV-fated interneurons through manipulation of
Shh signaling. In fact, loss of Shh signaling in embryonic mice initially reduces
proliferation in the MGE ventricular zone while simultaneously upregulating it in
the MGE SVZ125. Taken together, our study provides evidence that aPKCs play a
role in interneuron development and fate determination and may be doing so
through interactions with the NOTCH and Shh signaling pathways.
Although our study significantly enhances

the generation of PV-fated

interneurons, we also find that between 35-40% of cells lack expression of either
marker (Figure 2.5 C). This increase in non-labeled cells is approximately 1015% greater than reported in our previous studies, which typically show around
25% of cells being non-labeled269. The non-labeled cells are presumably Lhx6+
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on the basis of their being Lhx6:GFP+, and a substantial fraction also express
Sox6 and GABA (Figure 2.6). Thus, these cells are more likely to represent
MGE-like subtypes, as opposed to CGE-derived cells. In addition, staining for the
CGE-derived interneuron marker CR showed that less than 1% of all cells were
CR+ (data not shown). Since PV is an activity dependent gene, it is possible that
Lhx6:GFP+ cells who have sub-optimally integrated fail to turn on PV
appropriately. It would be interesting to do in situ hybridization for the potassium
channel Kv3.1, which colocalizes with PV but not SST subtypes, on transplanted
tissue.
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CHAPTER 3
Function of the Zinc Finger SWIM DomainContaining Proteins 5 & 6 in Forebrain Development

3.1 Introduction to Zinc-Finger SWIM Domain-Containing Proteins
Overview
Given evidence from our lab as well as others indicating that PV + interneurons
primarily arise from cyclin D2-mediated divisions of intermediate progenitors in
the MGE SVZ130,133, we set out to find candidate transcriptional regulators of
intermediate progenitor cell identity and/or proliferation. A literature search for
genes with patterns of expression restricted to the MGE SVZ led us to the zincfinger SWIM domain-containing protein 5 (Zswim5). Zswim5 was identified in a
microarray screen comparing gene expression profiles between the MGE and
LGE291. qPCR analysis showed that Zswim5 expression in the MGE was 4 fold
greater than in the LGE291. In situ hybridization for Zswim5 confirmed these
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findings and showed that its expression is largely restricted to a narrow band of
cells within the MGE SVZ291. Although no functional studies had been published
on Zswim5, it belongs to a family of zinc-finger SWIM domain-containing proteins
that are conserved across vertebrates292. In addition, RNAseq and microarray
data indicate strong, restricted expression of Zswim5 in the human MGE 293.
Thus, Zswim5 represented an ideal candidate for the study of SVZ proliferation
and its relationship to interneuron fate determination. In order to study Zswim5
function, we opted to generate Zswim5 loss-of-function mice. However, online
gene expression atlases indicated that Zswim5 had a highly homologous
paralogue, Zswim6, which was also expressed in the MGE293. Like Zswim5, no
studies on Zswim6 function had been published nor was it associated with any
diseases at the time. Thus, without additional data to indicate whether Zswim6
might compensate for Zswim5 loss-of-function, we opted to generate Zswim6
mutant mice as well. As will be described in this chapter, we found little to no
involvement for Zswim5 or Zswim6 in the regulation of PV + interneurongenesis.
Thus, we accepted our null hypothesis and set out to understand what other
processes these genes might regulate, which eventually led us to focus on
Zswim6 and its role in striatal development. The following chapter will consist of
three parts. The first part describes what is known about SWIM domaincontaining proteins, focusing on Zswim4, 5, 6, and 8. The second part will
investigate our early hypothesis that Zswim5 and Zswim6 regulate interneuron
development through the generation and characterization of Zswim5 and Zswim6
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loss-of-function mice. The third part will include a thorough anatomical and
behavioral characterization of Zswim6 mutant mice, with special emphasis on the
role of Zswim6 in striatal development.
SWIM Domain-Containing Proteins 4, 5, 6, and 8
SWIM protein domains are zinc-finger-like domains found in bacteria, archaea,
and eukaryotes292. As their name implies, zinc-finger domains bind zinc ions via
a combination of cysteine and histidine residues. Although they share this
commonality, zinc-finger domains are highly diverse in terms of their structure
and function. The SWIM domain has the amino acid motif CxCxnCxH, with n
varying between 6 to 25 residues292. Alignment across multiple species revealed
that SWIM domains are present in bacterial SWI2/SNF2 ATPases of the helicase
superfamily II, in which the SWIM domain is located at the N terminus, upstream
of the ATPase domain292. SWIM domains are also found in plant MuDR
transposases, plant FAR1 nuclear proteins, vertebrate MEK kinase-1, and
numerous uncharacterized proteins in prokaryotes and eukaryotes 292. Structural
analysis suggests that the SWIM domain adopts a ββα structure, which may be
similar to the classical C2H2 zinc-finger conformation292. Interestingly, in several
species of bacteria, genes that encode for SWI2/SNF2 ATPases that lack the
amino terminal SWIM domain are located adjacent to genes containing SWIM
domains, likely within the same operon. This suggests a functional link between
the two domains and that the origin of SWIM domain-containing ATPase proteins
may be related to the fusion of adjacent genes292. Of note, several eukaryotic
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SWIM domain-containing proteins also have an additional α-helix domain
downstream of the SWIM-domain. This feature is also found in bacterial SWIM
domain-containing SWI2/SNF2 proteins, suggesting that eukaryotic proteins with
this feature, such as Zswim5 and Zswim6, might functionally interact with
chromatin-associated SWI2/SNF2 ATPases of the Trithorax group of chromatin
remodelers/histone modifiers292.
In mammals, the SWIM domain-containing family of proteins has 8 members
(Zswim1 to Zswim8). Of these, Zswim4/5/6 and 8 are paralogues of each other.
With the exception of the SWIM domain, which is 37 amino acids long,
Zswim1/2/3 and 7 have little to no significant homology with Zswim4/5/6 and 8.
While Zswim4/5 and 6 are similar in structure and length (1100-1200 amino
acids), Zswim8 is much larger (~1800 amino acids), though still shares
considerable homology.

An analysis of comparative genomics shows that

Zswim4/5/6 and 8 all originated from the same ancestral gene found in bilateria
approximately 937 million years ago. From this ancestral gene, Zswim8 split off
and became EBAX-1 in C.elegans. A series of speciation and duplication events
in early vertebrates formed Zswim4 and the ancestral gene for Zswim5 and
Zswim6. Thus, Zswim5 and Zswim6 are closer to each other evolutionarily than
Zswim4 (Figure 3.1).
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Figure 3.1. Gene Tree for Zswim4, 5, 6, and 8 Gene Evolution
The above diagram represents a simplified gene tree of that contained within the
Ensemble Genome Browser and illustrates the evolutionary relationships between
Zswim4, 5, 6, and 8.

While the function of Zswim4/5/6 and 8 in mammals is currently unknown, the
homolog of Zswim8 in C.elegans, EBAX-1, has been studied. EBAX-1 is a
substrate recognition subunit in the Elongin BC-containing Cullin-RING ubiquitin
ligase (CRL) complex, which performs protein quality control by targeting
unfolded or misfolded proteins to the proteasome for destruction 1. During
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C.elegans development, EBAX-1 cooperates with DAF-21/Hsp90 to control the
protein quality of the SAX-3/Robo receptor, which is essential to ensure proper
axon targeting1. In the absence of EBAX-1, AVM axons are significantly
misrouted. EBAX-1 interacts with the CRL complex through its N-terminal BCbox and Cul2-box motifs, which are upstream of the SWIM domain and
conserved across species294. In HEK293 cells, ZSWIM8 has been shown to
interact with Elongin B/C proteins via its BC-box and the Cullin2 protein via its
Cul2-box294. A screen for additional proteins that could direct the recruitment of
Cul2 modules to Elongin BC-based ubiquitin ligases revealed that Zswim5 and
Zswim6 also contained these motifs and could bind Elongin BC 294. A follow-up
analysis of mine revealed that Zswim4 also contained the BC-box and Cul2
motifs (Figure 3.2).
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Figure 3.2. Multiple sequence alignment of BC- and Cullin-boxes in ZSWIM4,
5, and 6.
Protein sequences for human ZSWIM4, ZSWIM5, and ZSWIM6 were obtained from
NCBI’s protein sequence database and manually aligned to identify the BC- and
Cullin-box domains. Amino acids that are identical to classical BC- and Cullin-box
motifs are highlighted in yellow, very similar ones in blue, and similar amino acids in
green.
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The entire Elongin BC complex acts as an adaptor to link a substrate recognition
complex (e.g. Zswim8) to Cullin2 and a ring-box protein, such as Rbx1. The ringbox protein binds to an E2 ubiquitin ligase, which catalyzes the reaction of
ubiquitin onto the adaptor-linked substrate. In the case of Ebax-1, Hsp90 was
shown to bind the SWIM domain. Aside from the BC-box, Cul2, and SWIM
domains, Zswim4/5/6 and 8 also contain a conserved A domain downstream of
the SWIM domain that aligns to cut8/STS1, which targets proteasomes to the
nucleus295. The last ~75 amino acids of the C-terminus show similarity to
structurally defined portions of four paired amphipathic helix Sin3 proteins, which
have been shown to interact with RE1-silencing transcription factor (REST, or
NRSF) to repress the expression of neuron-specific genes in nonneural cells and
neuronal progenitors295 (Figure 3.3).
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Figure 3.3. Schematic illustration of putative Zswim-type cullin-RING E3
ubiquitin ligase
The following schematic is derived from studies of Ebax-1/Zswim8 in C.elegans1.
Ebax-1 encodes a conserved BC-box-containing protein and functions as part of a
protein quality control mechanism that ensures proper axon guidance. Specifically,
EBAX-1 functions as a substrate-recognition subunit for misfolded SAX-3 in an
Elongin BC-containing Cullin-RING ubiquitin ligase (CRL) complex that promotes
degradation of misfolded SAX-3/Robo receptor. The asterisk indicates that Hsp90
has been shown to bind Ebax-1 via its SWIM domain, but that this has not been
tested for Zswim5 or Zswim6.

Evidence suggesting that Zswim4/5/6 and 8 might bind to ring containing proteins
is interesting in light of their possible association with chromatin remodelers
and/or histone modification complexes. The Polycomb group of transcriptional
regulators is a group of proteins that bind to DNA and are traditionally thought to
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repress gene transcription. However, this view has been recently challenged by
new data indicating that Polycomb complexes can activate gene transcription in
certain contexts296,297. Polycomb group proteins usually belong to one of two
multi-subunit protein complexes, either Polycomb repressive complex 1 (PRC1),
which adds an ubiquitin residue to histone H2A at Lys119, or PRC2, which
catalyzes the addition of methyl groups to histone H3 at Lys27 298. Of particular
interest is the PRC1 complex, which is built around the RING domain-containing
proteins RING1 and RING2. These proteins bind to six alternative Polycomb
group RING finger (PCGF) proteins that together catalyze the transfer of ubiquityl
moieties298. A major question in the field of gene regulation centers on how
chromatin remodeling complexes such as Polycomb and Trithorax are
dynamically directed to regions of the genome at the appropriate time in a cell
type specific context to regulate gene expression. The ability to do so in part
stems from the various compositions of Polycomb and Trithorax group
complexes, of which upwards of 200 different permutations have been identified
and continues to increase297,299. These complexes have been shown to bind
transcription factors in a cell type specific manner that then recruit them to
specific regions of the genome. For example, REST/NRSF has been shown to
recruit Polycomb repressor complexes to distinct regions of the genome in
mammalian cells, as has the autism susceptibility candidate 2 (Auts2)296,300. It is
intriguing to speculate that Zswim proteins 4/5/6 and 8 might interact with these
complexes in a cell type specific manner during brain development to recruit
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them to specific genomic loci. As mentioned previously, Zswim proteins have
been shown to bind RING-domain containing proteins to catalyze the transfer of
ubiquityl moieties1,294. It would be interesting if Zswim proteins interacted with
PRC1

complexes to

regulate

histone H2A

ubiquitination during brain

development. Some support for this idea comes from a 2012 study that did a
mass spectrometry screen to identify proteins that interact with PRC1
complexes301. In this study, they found that Zswim6 immunoprecipitated with
PRC1 complexes in HEK293 cells, albeit only a single peptide301. Furthermore,
Zswim proteins are predicted to interact with mammalian SWI2/SNF2 complexes
through interactions with their N-terminal SWIM domain292. To test this idea, I
overexpressed Myc-tagged Zswim5 with HA-tagged Brg1 (the core ATPase
subunit of Trithorax complexes) in HEK293 cells and found that both proteins
were capable of immunoprecipitating the other (Figure 3.4).
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Figure 3.4. Zswim6 co-immunoprecipitates with Brg1, the main ATPase subunit
of SWI/SNF chromatin remodeling complex, in HEK293 cells.
(A) Myc-Zswim6 was co-expressed with HA-Brg1 in HEK293 cells. Myc-Zswim6 was
immunoprecipitated using anti-Myc magnetic beads and the eluant was run on
western blot. The blot was then probed using an anti-HA antibody, which detects a
clear band at ~220kD corresponding to HA-Brg1. The control indicates coimmunoprecipitation with nonreactive, non-antibody tagged magnetic beads.
(B) Myc-Zswim6 was co-expressed with HA-Brg1 in HEK293 cells. HA-Brg1 was
immunoprecipitated using anti-HA magnetic beads and the eluant was run on
western blot. The blot was then probed using an anti-Myc antibody, which detects a
clear band at ~132kD corresponding to Myc-Zswim6. The control indicates coimmunoprecipitation with nonreactive, non-antibody tagged magnetic beads.

The C-terminus of Zswim proteins 4/5/6 and 8 also have structural similarity to
Sin3 proteins, which have been shown to interact with REST/NSRF, SWI2/SNF2,
and NURD complexes to regulate gene transcription302,303. Further support for
this idea comes from analysis of Zswim5 and Zswim6 gene expression patterns
across human brain development. Using the Allen Brain gene expression atlas of
human brain development, it is possible to identify genes whose expression is
correlated with a gene of interest within particular brain regions across
development. Thus, I generated a list of 1000 genes whose expression is most
highly correlated with Zswim5 and Zswim6 across all areas of the brain from
early embryonic development up until adulthood. I then ran the top 1000 genes
through the DAVID functional gene classifier to segregate them into functional
groups by order of significance (Table 3.1).
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Table 3.1. Functional gene ontology analysis for genes whose expression
correlates with Zswim5 & Zswim6 expression during human brain
development.
The top 1000 genes whose expression most highly correlates with Zswim5 and
Zswim6 during human brain development were obtained from the Allen Brain Atlas.
For Zswim5 and Zswim6, correlated genes were ranked according to most
correlated (#1, #2, etc.) to least correlated. The rank values for genes correlated
with Zswim5 and Zswim6 were then combined to get a combined rank score. The
1000 genes with the lowest combined rank scores (most highly correlated with
Zswim5 and Zswim6) were then run though a functional gene ontology analysis
using the DAVID functional gene classifier. The top portion shows this analysis
done for the top 1000 genes, and the bottom portion shows this analysis done on
the top 50 genes. The same analysis done for genes correlated with either Zswim5
or Zswim6 (but not both) yielded similar results (not shown).

Functional annotation clustering revealed that the most significant cluster is
related to transcriptional regulation and zinc-finger (C2H2-like) proteins.

The

second most significant cluster was related to proteins localized to the nucleus
and the third most significant cluster is related to zinc-finger proteins. The fourth
most significant cluster and of particular relevance is related to chromatin
regulation, modification, and organization. Within just the top 50 associated
genes, at least 32 have been shown to be involved in transcriptional regulation,
chromatin remodeling, or histone modification (Table 3.1). I would argue that
proteins that function together are more likely to be expressed together, lending
further support to the notion that Zswim proteins may functionally interact with
chromatin remodeling/modifying complexes. If this were true, we would expect
Zswim5 to be predominantly localized in the nucleus, which is what we find when
recombinant Myc-tagged Zswim5 is expressed in HEK293 cells (Figure 3.5).
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Figure 3.5. Zswim5 predominantly localizes to the nucleus.
(A) Recombinant myc-tagged Zswim5 was expressed in HEK293 cells. Nuclear and
cytoplasmic fractionation followed by detection of the myc-tagged protein via western
blotting shows that the majority of Zswim5 protein is localized in the nucleus. Cyto,
cytoplasmic.

In sum, multiple lines of evidence, both direct and indirect, implicate the
involvement of Zswim4/5/6 and 8 in the regulation of gene expression through
interactions

with

Polycomb,

Trithorax,

and

other

chromatin

associated

complexes.
Zswim6 and Human Disease
From a human disease standpoint, the potential of Zswim4/5/6 and 8 to
participate in the process of chromatin modeling is interesting in light of evidence
showing that mutations in proteins associated with chromatin remodeling are
highly involved in the pathogenesis of major neurological and psychiatric
diseases such as epilepsy, autism, and schizophrenia 296,299,302,304-313. In a recent,
large scale genome wide association study for schizophrenia, a single nucleotide
polymorphism located ~50kB upstream of Zswim6 was identified as the 8 th most
significantly associated SNP in schizophrenia to date251. While little is known
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about

Zswim6

function,

its

dynamic

expression

during

human

brain

development293 and association with chromatin remodeling complexes makes it
well suited to be a schizophrenia candidate gene. Additionally, two studies have
identified the same, recurring point mutation in Zswim6 in patients with acromelic
frontonasal dysostosis295,314, a rare disorder characterized by brain, limb, and
craniofacial abnormalities. In at least 8 different probands a heterozygous
cysteine to threonine mutation at position 3487 has been identified, leading to an
arginine to tryptophan substitution at amino acid position 1163. Interestingly, this
mutation occurs in the Sin3-like C-terminal domain of Zswim6. From the
spectrum of clinical phenotypes, which include neurocognitive and motor delays,
severe symmetric frontonasal dysplasia associated with median cleft face, widely
spaced nasal alae, hypertelorbitism, bilateral tibial hemimelia, and preaxial
polydactyly, together with changes in gene expression in patient cell lines, the
authors of one of these studies concluded that this particular Zswim6 mutation
results in Hedgehog pathway activation295 (Figure 3.6).
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Figure 3.6. Craniofacial phenotype of a Zswim6 human mutation patient,
evolutionary comparative analysis, genomic structure, and predicted protein
regions.
(A). Anteroposterior view of the facial features of one patient shown to have a
c.3487C>T mutation in Zswim6.
(B). Coronal MRI demonstrating a large interhemispheric lipoma from the patient
shown in (A).
(C and D). Craniofacial CT scans showing disrupted cranial development, including
disruption of the nasal structures and medial cleft palate (C), and symmetric parietal
foramina (D).
(E). Protein alignments for the region surrounding the p.Arg1163Trp mutation
(yellow) for multiple species shows that this region is highly conserved. Divergent
residues are shown in red, and conservative substitutions are shown in green.
(F). Zswim6 contains 14 exons and spans a large genomic region. Only one
transcript has been described. Analysis of Zswim6 protein structure indicates that
Zswim6 has a low complexity, keratin-like N-terminal region, followed by the SWIM
domain, a cut8/STS-1 like region, and a sin3-like region at the C-terminus. The
location of the p.Arg1163Trp mutation is indicated by the black arrow.
Modified from Smith et al. 2014

Whether or not this proves true, it is interesting to note the similarities between
patients with Zswim6 mutations and those with mutations in members of the
SWI/SNF chromatin remodeling complex. De novo dominant mutations in
different SWI/SNF proteins have been identified in individuals with Coffin-Siris
(CSS)

and

Nicolaides-Baraitser

(NCBRS)

syndromes299,315,316.

CSS

is

characterized by mild to severe intellectual disability, hypoplasia of the tips of the
fingers and toes, and various craniofacial abnormalities 315. NCBRS is
characterized

by

severe

intellectual

disability,

seizures,

short

stature,

microcephaly, and facial coarseness316. Given the role of SWI/SNF proteins in
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regulating gene expression in multiple tissues, it is not surprising that mutations
in SWI/SNF proteins have pleiotropic effects of varying severity. While the
association is tenuous at best, it is intriguing to link mutations in Zswim6 to its
role as a putative chromatin modifier. As will be discussed in the forthcoming
sections, the heterozygous point mutation identified in Zswim6 is likely a
dominant gain-of-function mutation, since Zswim6 loss-of-function mice display a
much different phenotype than the human c.3487C>T point mutation patients 295.
3.2 Generation of Zswim5 and Zswim6 Knockout Mice and Characterization
of their Role in Interneuron Development
Generation of Zswim5 Knockout Mice
Over the course of these studies, we used two independently generated Zswim5
knockout mice. The first was obtained from the Knockout Mouse Project (KOMP)
and the second was designed in collaboration with Ingenious Targeting Labs,
who physically generated the mouse. The Zswim5 KOMP mouse (Z5-KOMP)
was generated using homologous recombination, whereby exons 2 and 3 were
replaced with a targeting cassette containing a lacZ reporter (Figure 3.7 A).
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Figure 3.7. Targeting strategy and characterization of Zswim5 knockout mouse
obtained from the Knockout Mouse Project (KOMP).
(A). Schematic of the Zswim5 locus after homologous recombination with a targeting
construct electroporated into mouse embryonic stem cells. Exons 2 and 3 are
replaced by the targeting construct, which contains a lacZ reporter gene. The
neomycin (neo) insert was removed by crossing heterozygous mice to FLP-deleter
mice before beginning our studies.
(B). Detection of β-galactosidase in embryonic day (E) 13.5 Zswim5 lacZ/+ and control
mice shows that lacZ expression recapitulates Zswim5’s endogenous expression.
(C). In situ mRNA hybridization of three different RNA probes to various regions of
the Zswim5 transcript in wildtype and knockout mice. As expected, a probe spanning
the exons removed in the knockout mouse (exon 2-4 probe) shows no signal,
whereas probes to regions downstream of the deleted region detect the presence of
residual transcript.
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This results in a frameshift mutation that is predicted to cause nonsense
mediated decay of the transcript. Importantly, there is only one known transcript
for Zswim5. While a southern was not done to confirm the targeting, several
other quality control measures were, including long range PCR and copy number
testing (data not shown). In addition, lacZ staining on E13.5 Zswim5lacZ/+ mouse
forebrain confirms that the lacZ reporter recapitulates endogenous Zswim5
forebrain expression (Figure 3.7 B). To determine whether this mouse was a
functional null, we first did in situ hybridization with a probe directed against
exons 2 and 3, which were replaced with the targeting construct. As expected,
knockout tissue showed no signal with this probe when compared to wildtype.
However, in situ hybridization using several other probes downstream of the
deleted exons showed that the transcript was still present in knockout mice
(Figure 3.7 C).To determine whether alternative transcripts might be present that
could still produce a functional protein, such as through exon skipping, we did 5’
RACE and found no alternative transcripts (data not shown). With no evidence to
suggest that an alternative transcript with protein-coding potential was being
transcribed, we considered this mouse a functional null.

From a biological

standpoint, the in situ analysis we performed highlights the fact that not all
transcripts may be subject to nonsense mediated decay to the same extent, and
in the case of Zswim5, a substantial amount of mutant transcript remained. Since
this mouse was a constitutive knockout, we wanted the ability to conditionally
inactivate Zswim5 as well. Thus, we generated a conditional knockout (Z5-ITL) in
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collaboration with Ingenious Targeting Labs. To generate this mouse we used
homologous recombination to flank exon 3 with loxP sites (Figure 3.8 A), which
upon Cre-recombinase mediated recombination is predicted to cause a
frameshift deletion. Southern blot using 3’ and 5’ DNA probes indicates that the
targeting construct inserted at the correct location (Figure 3.8 B). To confirm
whether this strategy produced a null allele, we bred Zswim5 floxed mice to a
CMV-Cre line (Jackson Laboratory Stock #006054) to produce a germline
knockout. Using cDNA from the offspring, we did RT-PCR with a primer set
containing a forward primer in exon 2 and a reverse primer in exon 3 and found
no band at the expected length relative to control (Figure 3.8 C). Additionally,
qPCR on E13.5 mouse forebrain showed that Zswim5 transcript was reduced by
approximately 75% in knockouts relative to control. Together, these studies
indicate that both Zswim5 mutant mouse lines are highly likely to be functional
nulls (Figure 3.8 D).
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Figure 3.8. Generation of Zswim5 knockout (KO) mice.
(A). Schema of constructs used in generating a null allele for Zswim5 by flanking
exon 3 with LoxP insertions, generating a mouse line, then crossing this line with
Cre-deleter mice.
(B). Southern blot analysis to identify correctly targeting embryonic stem (ES) cell
clones obtained from hybrid C57BL/6x129/SvEv ES cells electroporated with the
targeting construct. One ES clone (A1) was identified in which there was the
expected 5’ and 3’ recombinations. HYB, hybrid ES cell; B6, C57BL/6 ES cell; 129,
129/SvEv ES cell.
(C). RT-PCR reveals a loss of product created by primers flanking the exon 2 and 3
junction in the Zswim5 knockout.
(D). There is a 75% reduction in the relative abundance of Zswim5 mRNA in

homozygous Zswim5 KO mice (N=3). Abbreviations: WT (wild type); Neo
(neomycin resistance cassette); E (exon). *p<.001. Error bars indicate SEM.

Study of Interneuron Development in Zswim5 Knockout Mice
To begin our study of Zswim5, we first characterized its expression using in situ
hybridization. We find that at E12.5, E14.5 and E16.5, Zswim5 mRNA is
predominantly restricted to the MGE SVZ, with low levels of expression in the
LGE SVZ and cortical plate (Figure 3.9). By P0, Zswim5 expression is
undetectable (data not shown). Next, we turned our attention to analysis of Z5KOMP mice. Observation of adult Zswim5 knockouts revealed no obvious
behavioral, neurological, or anatomical phenotypes. We next examined whether
loss of Zswim5 affected proliferation of MGE progenitors. We counted ventricular
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and abventricular phospho-histone H3 mitotic figures and found a non-significant
14% and significant 9% decrease, respectively, in knockouts relative to controls
(Figure 3.10 A). We also pulsed with EdU for 30 min at E13.5 to look at the

Figure 3.9. Expression of Zswim5 in the developing mouse forebrain.
In situ mRNA hybridization for Zswim5 shows strong expression in the medial
ganglionic eminence (MGE) at embryonic day (E) 12.5, 14.5, and 16.5. Low levels
of expression can also be detected in the lateral ganglionic eminence (LGE) and
cortex (Cx).

fraction of progenitors in S-phase. Although we did not quantify the number of
EdU+ progenitors, qualitatively there did not appear to be an obvious difference
(Figure 3.10 B). This was also true for the SVZ marker cyclin D2 (Figure 3.10
B). Immunohistochemistry for Lhx6 also revealed no obvious changes in the
production and/or specification of interneuron precursors (Figure 3.10 B). In
agreement with these findings, we found no significant difference in the number
of PV interneurons in the somatosensory cortex or hippocampus of P21 Z5KOMP mutants (Figure 3.11). On the basis of these results, and the observation
88

that Zswim6 is also expressed in the MGE and may compensate for Zswim5
loss-of-function, we decided to turn our attention away from Zswim5 single
knockouts and focus on Zswim5/Zswim6 double mutant mice.

Figure 3.10. Analysis of proliferation and molecular specification in the medial
ganglionic eminence (MGE) of Zswim5 mutant mice.
(A). Immunostaining for the M-phase marker phospho-histone H3 on embryonic day
(E) 13.5 mouse forebrain sections shows that there is no change in ventricular zone
(VZ) mitoses and a 9% reduction in subventricular zone (SVZ) mitoses.
(B). Immunostaining for Lhx6, a marker of post-mitotic, MGE-derived neocortical
interneurons shows no gross differences between Zswim5 knockout mice (KO) and
wildtype (WT) controls. Similarly, examination of the SVZ proliferation marker CD2
and the thymidine analogue EdU, which marks cells in S-phase, shows no gross
changes in the KO relative to controls.
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Generation of Zswim5/Zswim6 Double Knockout Mice
Zswim5 and Zswim6 are highly homologous proteins. If one considers identical
and identical/similar amino acids, they are 77% and 87% homologous,
respectively.

Figure 3.11. Cortical parvalbumin interneuron numbers are normal in Zswim5
knockout mice.
Counts of parvalbumin-expressing interneurons (PV) in primary somatosensory
cortex (S1) and hippocampus (HPC) shows no difference in the number of PV
interneurons in Zswim5 knockout mice relative to controls.

They are also expressed in largely overlapping patterns, increasing the likelihood
of genetic compensation. In order to generate Zswim6 mutants, we adopted a
conditional knockout strategy that was similar in approach to Zswim5. Since
Zswim5 and Zswim6 were formed through gene duplication, they have a nearly
identical genomic structure. The only major difference is that exon 1 in Zswim5
was split into two exons in Zswim6. Thus, exon 3 in Zswim6 is identical to exon 2
in Zswim5. Zswim5 has 14 exons in total and Zswim6 has 15, with exons 1 and 2
being equivalent to exon 1 in Zswim5. Like our Zswim5 conditional mutant, we
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used homologous recombination to flank exon 4 of Zswim6 with loxP sites
(Figure 3.12 A), which upon Cre-recombinase mediated recombination is
predicted to cause a frameshift deletion. Southern blot using 3’ and 5’ DNA
probes indicates that the targeting construct inserted at the correct location
(Figure 3.12 B). To confirm whether this strategy produced a null allele, we bred
Zswim6 floxed mice to a CMV-Cre line to produce a germline knockout. We then
did in situ mRNA hybridization using a probe against the deleted exon to confirm
its deletion (Figure 3.12 C). Using cDNA E13.5 KOs, we also did RT-PCR with a
primer set containing a forward primer in exon 3 and a reverse primer in exon 4
and found no band at the expected length relative to control (Figure 3.12 D).
Additionally, qPCR on adult mouse striatum showed that Zswim6 transcript was
reduced by approximately 70% in knockouts relative to control (Figure 3.12 E). A
more detailed analysis of Zswim6 single knockout mice will be provided in the
following data section. In order to generate constitutive Zswim5/Zswim6 double
knockouts, we bred each floxed line to CMV-cre line as previously described.
After breeding out the CMV-cre allele, we bred the offspring together to generate
Zswim5+/-Zswim6+/- compound heterozygotes. These were subsequently bred to
generate Zswim5-/-Zswim6-/- double knockout mice.
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Figure 3.12. Generation of Zswim6 null mutant mice.
(A). Schema of constructs used in generating a null allele for Zswim6 by flanking
exon 4 with LoxP insertions, generating a mouse line, then crossing this line with
Cre-deleter mice.
(B). Southern blot analysis to identify correctly targeted embryonic stem (ES) cell
clones obtained from hybrid C57BL/6x129/SvEv ES cells electroporated with the
targeting construct. Four ES clones (Z1-Z4) were identified in which there was the
expected 5’ and 3’ recombinations. HYB, hybrid ES cell; B6, C57BL/6 ES cell; 129,
129/SvEv ES cell.
(C). In situ hybridization (ISH) for Zswim6 using a probe spanning exon 3 to the
beginning of exon 5 shows loss of expression in coronal sections from embryonic day
(E) 14.5 forebrain of homozygous Zswim6 nulls.
(D). RT-PCR reveals a loss of product created by primers flanking the exon 4 and 5
junction in the Zswim6 KO.
(E). There is a significant reduction in the relative abundance of Zswim6 mRNA in
homozygous Zswim6 KO mice (N=3). Abbreviations: WT (wild type); Neo (neomycin
resistance cassette); E (exon). ***p<.001. Scale bar 400μm in C. Error bars SEM.
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Study of Interneuron Development in Zswim5/6 Double Knockout Mice
While

Zswim5

knockouts

have

no

observable

phenotype,

constitutive

Zswim5/Zswim6 double knockouts die within the first 24-48 hours after birth.
These mice have no obvious deformities, are well perfused without cyanosis, and
have visible milk spots. Thus, their cause of death remains largely unknown.
Since parvalbumin and somatostatin are not expressed in PV + and SST+ fated
cortical interneurons, respectively, until early adolescence in both mice and
humans317,318, the early fatality of these double mutants precludes any analysis of
adult cortical interneuron numbers. Thus, we took advantage of our mutant
mouse lines’ conditional potential and generated Nkx2.1-cre double mutants
(Nkx2.1dKO)44. The Nkx2.1-cre line allows us to interrogate the function of
Zswim5 and Zswim6 within Nkx2.1-expressing progenitors of the MGE and
PoA44. While this line also expresses cre-recombinase in other tissues that
express Nkx2.1, including the hypothalamus, thyroid, and lung, we did not
examine these structures44. Nkx2.1dKO mice do not differ from their wildtype
littermates in terms of survival or size (data not shown). Stereological analysis of
cortical and striatal volumes showed no change in the volume of either structure
(Figure 3.13 A). Next, we counted the number of PV+ and SST+ interneurons in
the cortex and striatum of Nkx2.1dKO mice and found no difference in the
number of either subgroup relative to controls (Figure 3.13 C). We also counted
striatal ChAT+ interneurons, which originate from Nkx2.1+ progenitors in the
MGE, and found a 20% decrease in their total number (Figure 3.13 C). Naturally,
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we followed up on this finding by examining whether either of the single mutants
showed a reduction in striatal ChAT+ cells and found that neither of them did
(Figure 3.13 B).
Discussion
Here, we examined the role of Zswim5 and Zswim6 in the production of cortical
and striatal interneurons. Analysis of Zswim5 single mutants showed no change
in the number of PV+ cortical interneurons. Armed with this data and knowledge
of Zswim6 expression in the MGE, we opted to analyze Nkx2.1dKO mice in lieu
of spending additional time and resources examining Zswim5 single mutants.
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Figure 3.13. Analysis of striatal and cortical volume and interneuron numbers
in Nkx2.1-cre Zswim5/Zswim6 double knockout mice.
(A). Nkx2.1-cre Zswim5/Zswim6 (Nkx2.1dKO) mice have no change in cortical (Cx)
or striatal (STR) volume.
(B). Constitutive Zswim5 and Zswim6 single knockout (KO) mice have no change in
the number of striatal cholinergic interneurons.
(C). Nkx2.1dKO mice have no change in cortical and striatal parvalbumin- (PV) or
somatostatin (SST)-expressing interneurons but have a 20% decrease in the number
of striatal cholinergic interneurons. ***p<.001. Error bars indicate SEM.

The observation that constitutive double knockouts die shortly after birth
suggests that Zswim5 and Zswim6 can at least partially compensate for loss of
one another. In support of this, we found no change in the number of striatal
ChAT+ interneurons in either of the single mutants, but found a 20% reduction of
ChAT+ interneurons in Nkx2.1dKO mice. PV+, SST+ and ChAT+ interneurons are
derived from common Nkx2.1+ progenitors, which upon exit from the cell cycle
express Lhx6, GABA, and, at least in a subset, Lhx7 116. In cells that are fated to
become cholinergic subtypes Islet1 is upregulated116. Islet1 is cross repressive
with Lhx6 and causes it to downregulate in ChAT + fated cells. Interestingly, Lhx7
is required to maintain Islet1 expression, and lack of Lhx7 causes cells to revert
into a default, GABAergic Islet1-/Lhx6+ lineage114,116. Together, Lhx7 and Islet1
form a complex that activates a forebrain cholinergic transcriptional program 115. A
key question that remains to be addressed is the mechanism by which nascent
Lhx6+, bipotential precursors that are destined to become cholinergic cells
upregulate Islet1. It is intriguing to speculate that Zswim5 and Zswim6 might
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participate in this process. In addition, further work is necessary to understand
the ultimate fate of the missing ChAT+ cells. We did not find an increase in the
number of striatal PV+ or SST+ subtypes, suggesting that the missing ChAT +
cells did not simply adopt a GABAergic identity. It remains to be resolved
whether these cells die, migrate elsewhere, adopt another identity, were ever
produced in the first place, or simply fail to express choline acetyl transferase.
Regardless, this finding has important implications, since dysfunction of
cholinergic transmission within the ventral telencephalon is thought to contribute
to a number of disease processes including Alzheimer’s, Parkinson’s, Tourette’s,
schizophrenia, and addiction229,230,319-322.

3.3 Loss of the Schizophrenia Associated Gene Zswim6 Alters Striatal
Development and Motor-Dependent Behaviors
Overview
The zinc-finger SWIM domain-containing protein 6 (ZSWIM6) is a little studied
protein with unknown function that has been associated with schizophrenia by
two independent genome-wide association studies. More recently, a recurrent
point mutation in ZSWIM6 has been identified in several cases of acromelic
frontonasal dysostosis and thought to be causal in the disorder. Despite the
growing number of studies implicating ZSWIM6 as an important regulator of brain
development, its role in this process has never been examined. Here, we report
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the generation of Zswim6 knockout mice and provide a detailed anatomical and
behavioral characterization of the resulting phenotype. We show that Zswim6 is
initially expressed widely during embryonic brain development but becomes
restricted to the striatum postnatally. Loss of Zswim6 causes a reduction in
striatal volume and changes in medium spiny neuron morphology. These are
associated with alterations in motor behaviors including hyperactivity, impaired
rotarod performance, repetitive hopping, and behavioral hyperresponsiveness to
amphetamine. Together, our results show that Zswim6 is indispensable to normal
brain development and support the notion that Zswim6 might serve as an
important contributor in the pathogenesis of schizophrenia.
Introduction
While neuropsychiatric disorders such as schizophrenia (SCZ) exhibit significant
heritability, the underlying genetics are complex, involving multiple perturbations
of modest effect size acting within critical temporal windows323. Efforts to
understand the pathophysiology of SCZ are similarly complicated by the
disorder’s diverse, partially penetrant symptomology, organized loosely around
positive (hallucinations/ delusions and movement abnormalities) and negative
(altered affect, reduced pleasure and motivated action) behavioral domains.
However, after many years of stagnation, advances in genomic sequencing,
coupled to an appreciation for the scale at which studies must be conducted in
order to identify common risk alleles of small effect, have started to uncover the
genetic building blocks of polygenic diseases such as SCZ. While knockout
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animal models offer admittedly limited insight into the complex nature of these
disorders, they may be useful in identifying molecular pathways and neural
circuits that are uniquely vulnerable to genetic insult and that have central
functions in regulating behavioral output. Here, we contribute to the study of
these variants through the generation and characterization of one such SCZassociated risk gene, ZSWIM6. While to our knowledge no functional studies
have been published on ZSWIM6, two independent genome-wide association
studies have implicated it in SCZ251,324 and several additional studies have
documented its expression in developing and adult brain 293,295,325,326. At least two
clinical studies have also identified a recurrent point mutation in ZSWIM6 in
cases of acromelic frontonasal dysostosis, a rare disorder characterized by
multiple brain, limb, and craniofacial abnormalities295,314. And while few of the
known protein domains within ZSWIM6 are well characterized, gene ontology
studies suggest that ZSWIM6 may participate in the epigenetic regulation of gene
transcription through interactions with chromatin remodeling complexes 292— a
process extensively implicated in SCZ pathogenesis305,308,309.
Recent evidence has implicated cortico-striato-thalamic circuit dysfunction in
multiple neuropsychiatric diseases exhibiting motor and cognitive behavioral
components223,327, reflecting the wide-ranging function of these pathways in
motor control, decision-making and reward processing. Due in part to the
dominance of the “dopamine hypothesis,” the striatum has long been considered
a site of SCZ pathology, although how physiological dysfunction contributes to
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specific behavioral abnormalities remains unclear. Here, through the generation
of Zswim6 knockout (KO) mice, we provide evidence that further implicates
striatal dysfunction in the manifestation of neuropsychiatric disease. We show
that Zswim6 initially exhibits widespread early embryonic expression in many
forebrain regions, but becomes progressively restricted to the adult striatum.
Consistent with this highly restricted expression pattern, we observed that
Zswim6 KO mice exhibit a range of motor abnormalities consistent with striatal
dysfunction. Many of our findings are similar in nature to phenotypes observed in
SCZ patients, suggesting that Zswim6 KO mice may serve as a useful model for
studying SCZ-associated endophenotypes.
Results
Expression of Zswim6 in the developing and adult forebrain
To confirm previous reports and to examine Zswim6 across forebrain
development, Zswim6 expression was evaluated by mRNA in situ hybridization.
Zswim6 was detected in the subventricular zone (SVZ) of the LGE and MGE at
E12.5 (Figure 3.14 A-C). Higher expression levels appeared in the LGE than
MGE. By E14.5 this expression remained enriched in the SVZ (Figure 3.14 E-G),
extending into more proximal regions of the MGE and LGE mantle regions. By
E16.5, this expression expanded into the medial cortex, the developing
amygdala, and portions of the thalamus and hypothalamus (Figure 3.14 G-I). In
the telencephalon, the postnatal expression of Zswim6 became more restricted
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to the striatum (Figure 3.14 J). Similar expression patterns have been identified
in human samples (Figure 3.15).
Generation of a Zswim6 null mouse
These expression studies suggest that Zswim6 is expressed in the anlagen and
postnatal tissue of several portions of the “limbic” forebrain. This expression
pattern and the association of Zswim6 with schizophrenia led us to evaluate
whether loss of Zswim6 would alter forebrain development and function. Gene
targeting was used to create a null allele (Figure 3.12 A) in which exon 4 was
flanked by LoxP sequences. Removal of exon 4 was predicted to result in a
frameshift mutation. Southern blotting was used to identify correctly targeting
embryonic stem cell clones (Figure 3.12 B). Crosses with a germline expressed
Cre recombinase line (CMV-Cre) resulted in generation of an allele lacking
expression of Zswim6 exon 4 by in situ hybridization and RT-PCR (Figure 3.12
C, D). The MGE of homozygous mutants expressed Zswim6 transcript at roughly
35% of control levels at E13.5 (Figure 3.12 E). Of note, in silico analysis
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Figure 3.14. Zswim6 expression
during striatal development.
At embryonic day (E) 12.5 (A-C)
and E14.5 (D-F) Zswim6 is
strongly expressed in the in the
subventricular zone of the lateral
and medial ganglionic eminences
but at low to non-detectable levels
not in the cerebral cortex. Low
level expression can also be seen
in the amydala (arrow in F) and
thalamus (G-I). At E16.5 this
expression expands to the cortical
plate and medial habenula (arrow
in I) and increases in intensity in
the amygdala, as well as the
amygdala (arrow in H). (J) Image
from the Allen Brain Atlas shows
that expression of Zswim6 is
present in the adult striatum but
not in the overlying cerebral
cortex. Abbreviations: LGE (lateral
ganglionic
eminence);
MGE
(medial ganglionic eminence);
CGE
(caudal
ganglionic
eminence); Cx (cortex); Th
(thalamus); Am (amygdala); Hy
(hypothalamus); St (striatum).
Scale bars 300μm in A-C, 400μm
in D-F, 500μm in G-I, 1000μm in
J.

suggests that Zswim6 has a single transcript. Unfortunately, while the loss of
exon 4 transcript and striatal-related phenotypes presented in this paper are
highly encouraging that a Zswim6 null has been created, we were unable to
confirm Zswim6 protein expression using commercial antibodies.
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Figure 3.15. Zswim6 expression during human fetal forebrain development.
(A) and (B) are pseudocolored renderings from the Allen Brain Institute’s human
prenatal microarray study showing the relative expression levels of Zswim6 in
different embryonic forebrain regions.
(A). Shows the relative expression of Zswim6 in different forebrain regions from a
single post-conception week (pcw) 21 sample. The sections are arranged from
rostral to caudal. Red indicates higher levels of expression, whereas lower levels are
indicated in green. The “1” marks the lateral ganglionic eminence. “2” marks the
caudate nucleus. “3” marks the putamen. “4” marks the cortex.
(B). Shows the relative expression of Zswim6 at three different embryonic time
points at approximately the same coronal level. Each time point represents data from
a single donor. The expression pattern in the anlage of the striatum is quite similar to
that of Zswim6 in the mouse. The labeled structures are the same as in (A).

Abnormal neocortical and striatal development in Zswim6 null mice.
Zswim6 KO mice were born in Mendelian ratios, but showed increased neonatal
mortality such that roughly 40% of Zswim6 KO mice survived to weaning (Fig.
Figure 3.16 A, B). At postnatal day (PD) 21, their weight averaged about 80% of
wild-type controls (Figure 3.16 C), although this normalized improved to 93% of
controls by adulthood (Figure 3.16 C). Analysis of overhead-view surface area in
adults showed a significant decrease for the Zswim6 KO cerebral cortex, and no
such decrease for the cerebellum (Figure 3.16 D). Stereological analysis of
cortical and striatal volumes by the Cavalieri method showed a 7% decrease of
cortical volume and a 15% decrease in striatal volume (Figure 3.16 D).
To determine which components of forebrain volume were contributing to the
above-mentioned phenotypes, we conducted stereological counting of immunelabeled neuronal subtypes in the dorsal striatum (striatum dorsal to the N.
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Acumbens) of adult mice. Remarkably, relative to wild-type controls Zswim6 nulls

Figure 3.16. Decreased early postnatal survival and forebrain size in Zswim6
null mutants.
(A). Survival plot showing that the null mutant (KO) mice have a 40% mortality in the
first few days after birth, followed by a very gradual decline through 4 weeks. Data is
from approximately 100 mice from each group.
(B). Analysis of the % of litters that are wild type (WT), heterozygous (HET) or KO for
Zswim6 at embryonic day (E) 14.5, P0, and P21 is consistent with loss of KO pups
after birth (N=79 mice for P21, chi-square with 2 degrees of freedom = 27.911).
(C). Zswim6 KOs also show a small decrease of weight relative to controls at P21
that persists into adulthood (N=10).
(D). Overhead surface area of the cerebral cortex (Cx) shows a significant decrease
in the Zswim6 KOs, but no change in the cerebellum (N=5). Volumetric
measurements based on analysis of coronal tissue sections show a significant
reduction of volume in both the Cx (N=5 WT, 6 KO) and the striatum (St; N=5).
*p<.05, ** p<.01, ***p<.001, #p<.0001. Error bars indicate SEM.
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showed a 17% reduction in the number of nuclei labeling with CTIP2, a marker of
medium spiny neurons (Figure 3.17 A). However, the density of these neurons
was not changed. In contrast, there was no change in the number of two major

Figure 3.17. Zswim6 null mutants have a reduced number of medium spiny
neurons.
(A). Cell counts for the medium spiny neuron marker CTIP2 in adult Zswim6 KOs
relative to WT controls shows a significant reduction of cell number in the KOs. On
the other hand, cell density is unchanged, consistent with the reduced total dendritic
length (N=3; see Fig. 5) combined with cell loss.
(B). In contrast to the effects on medium spiny neurons, cell counts for several
populations of striatal interneurons (choline acetyl transferase, ChAT; parvalbumin,
PV; somatostatin, SST) are unchanged (N=3).
(C). Semi-quantitative RT-PCR for striatal transcripts, including the dopamine
receptors Drd1 and Drd2, were not altered in the Zswim6 KOs (N=3). Interestingly, in
the KOs there was a trend for increased levels of Zswim5, which might be
compensation by this close homologue to Zswim6. *p<.05. Error bars indicate SEM.
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subclasses of GABAergic striatal interneurons (Figure 3.17 B), defined by
parvalbumin (PV) and somatostatin (SST). In addition, there was no change in
the number cholinergic interneurons defined by their expression of choline-acetyl
transferase (Figure 3.17 B). There were no gross alterations in the expression of
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Figure 3.18. Dendritic abnormalities in striatal medium spiny neurons of
Zswim6 null mutants.
(A). The number of primary dendrites, dendritic ends (tips), and total length were
decreased in the KOs, whereas there was an insignificant trend towards a reduced
number of branch points, and no difference in mean length (N=3, 7 MSN/animal).
(B). Consistent with the results in (A), Scholl analysis revealed decreased cumulative
length and number of intersections in the KOs.
(C). Shows an example of the reconstructions from Golgi-stained sections used in
these analyses.
(D). Spine density was also decreased on the medium spiny neurons of Zswim6
KOs. Scale bars 50μm in C, 5μm in D. *p<.05, ** p<.01, ***p<.001. Error bars
indicate SEM.

dopamine receptors DRD1 or DRD2 by in situ hybridization (data not shown),
and no gross change in tyrosine hydroxylase or DARPP32 (data not shown).
Finally, there were no statistically significant changes in the expression of striatal
genes evaluated by qPCR (Figure 3.17 C), including GPR88, PENK, Adora2a,
Drd1, Drd2, Rgs4, TAC1, and GPR6. Interestingly, there was a non-significant
trend for Zswim5 upregulation, by 20%.
In addition to neuronal number, another important component to striatal size is
dendritic arborization. Indeed, reconstructions of Golgi-stained neurons revealed
a significant decrease in dendritic number, tips, and total length (Figure 3.18 A,
C). There was no change in the number of branch points or mean dendritic
length. Sholl analysis revealed that Zswim6 KOs have reduced cumulative
dendritic length and decreased Sholl intersections (Figure 3.18 B). Spine density
was reduced in the KOs by about 15% (Figure 3.18 D).
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These results suggest that the reduction of striatal volume involves both a
reduction in the number of medium spiny neurons, and a reduction in their
dendrites. To determine whether the dendritic arborization phenotype is specific
to the striatum, we examined layer 3 pyramidal neurons of the medial frontal
cortex. While the apical dendrites of Zswim6 KO pyramidal neurons were
unchanged from controls, the basilar dendrites had reduced dendritic complexity
and length (Figure 3.19 A, B). This result contrasted to that of layer 3 of
somatomotor cortex, which was not altered in the Zswim6 KO brains (Figure
3.19 A). As for the striatum, Sholl analysis of the medial frontal cortical layer 3
pyramidal neuron basilar dendrites revealed that Zswim6 nulls have reduced
cumulative dendritic length and decreased Sholl intersections (Figure 3.19 C).
Again, these differences were not found in the basilar dendrites of layer 3
pyramidal neurons in somatomotor cortex (Figure 3.19 C). Spine density on
medial frontal cortical layer 3 pyramidal neuron basilar dendrites was reduced by
about 13% (Figure 3.19 D).
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Figure 3.19. Zswim6 null mutants have decreased dendritic complexity in
medial frontal cortex but not somatomotor cortex.
(A). For pyramidal neurons (PN)s of the medial frontal cortex (mfCx), the Zswim6
KOs had a significant decrease of branch points, tips, total length and mean length in
the basilar dendritic tree, whereas the apical trees were not affected. In contrast, the
basilar dendrites were unchanged in the KOs somatomotor cortex (smCx) (N=3, 6
PN/animal)
(B). Shows an example of the reconstructions from Golgi-stained sections used in
these analyses.
(C). Sholl analysis of the basilar dendrites revealed decreased cumulative length and
number of intersections in the mfCx of the KOs, but no change in the smCx.
(D). Spine density was also decreased on the basilar dendrites of Zswim6 KO mfCx
pyramidal neurons . Scale bar 50μm in B. ** p<.01, ***p<.001. Error bars indicate
SEM.

To evaluate potential mechanisms behind the reduction of striatal medium spiny
neurons, we quantified markers of proliferation during embryonic development.
Counts of the m-phase marker PH3, and the S-phase marker EdU, showed no
differences in the LGE between Zswim6 KO embryos and wild-type controls
(Figure 3.20). In addition, there was no gross difference in the density of cells
expressing cyclin-D2, expressed primarily in subventricular zone progenitors
(data not shown). While these analyses cannot definitely rule out the presence of
a relatively subtle proliferation deficit, they do suggest that the adult striatal
phenotype in Zswim6 KO embryos is not secondary to a major proliferation
deficit. In addition, we also investigated the presence of cleaved caspase-3 as an
indicator of apoptosis in Zswim6 KO and control mice at E14.5, P0, P21, and P60
and found no increase in its expression (data not shown).
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Figure 3.20. No evidence for reduced proliferation by striatal progenitors in
Zswim6 null mutants.
(A). At embryonic day (E) 14.5, mice were pulsed with the thymidine analogue EdU
30 minutes before fixation and the location of s-phase cells identified by
histochemistry. The boxed region shows the areas for which EdU+ nuclei were
counted in the lateral ganglionic eminence, the origin of medium spiny neurons of
the adult striatum. There were no differences in EdU expression in the Zswim6 KOs.
(B). PH3 labels m-phase cells. Again, there were no differences in this marker of
proliferation in either the ventricular zone (bin 1) or subventricular zone (bins 2 and
3) of the KOs relative to WT controls (N=5). Scale bar 300μm. Error bars indicate
SEM.

Loss of Zswim6 results in behavioral deficits
To determine whether the alterations in medium spiny neuron number and
arborization are accompanied by behavioral abnormalities in Zswim6 nulls, mice
were subjected to a battery of tests. Consistent with an alteration of striatal
function, Zswim6 nulls had a performance worse that controls on the rotarod
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(Figure 3.21 A). In the open field test they showed increased horizontal beam
breaks, increased rearing, and decreased thigmotaxis (Figure 3.21 B).
Hyperactivity was also apparent in the force plate test, and hind limb jumping
was greatly increased (Figure 3.21 C). In agreement with the open field findings,
Zswim6 nulls also had fewer low mobility bouts and spent less time in the center
of the arena (Figure 3.21 C). In the elevated zero maze the Zswim6 nulls
showed a non-significant trend towards increased time in the open arm, and an
increased average speed (Figure 3.21 D). Remarkably amphetamine, at a dose
(2mg/kg) that did not alter the activity of controls, significantly increased the
activity of the Zswim6 nulls (Figure 3.21 E). This result is consistent with
enhanced striatal dopamine signaling in these mutants.
We also attempted to assess sensorimotor gating by measuring prepulse
inhibition (PPI) of the acoustic startle reflex. However, during the initial acoustic
habituation trials, we discovered that Zswim6 nulls have a dramatically blunted
response to increasing auditory stimulation, indicating a potential for hearing loss
(Figure 3.22 A). Follow-up brainstem auditory evoked response testing (ABR) on
three Zswim6 nulls revealed that two animals had normal ABR thresholds to a 16
kHz pure tone, which is the frequency at which mice hear best, while one animal
had no response (Figure 3.22 A, C, D). Overall, knockout mice did not appear to
have altered thresholds over a 20 kHz range (Figure 3.22 C).
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Discussion
To our knowledge this is the first paper to describe a loss of function model of the
schizophrenia-associated gene Zswim6 in mice. Zswim6 is strongly expressed
within the subventricular and mantle zones of the striatal anlage. Broadly, it has a
dynamic expression pattern in multiple regions, including the medial frontal
cortex, medial habenula, and the amygdala. This expression pattern in regions of
the “limbic” forebrain is particularly intriguing in light of the association of Zswim6
with schizophrenia.
Zswim6 null mutants are born at Mendelian ratios, but roughly half fail during the
neonatal age range. The cause of this death is not clear, but the Zswim6 mutants
lag behind their littermates in weight through weaning and into adulthood, then
appear to breed normally. Due to the strong persistent expression of Zswim6 in
the adult striatum, where the close homologue Zswim5 is weakly expressed, and
due to the relevance of striatum to the pathology of schizophrenia, we focused on
striatum and related phenotypes in this study.
Striatal volume was reduced by 15% in Zswim6-/- adults. This occurred in part
due to a reduction in the number of medium spiny neurons (Figure 3.17). To
examine the mechanism of reduced medium spiny neuron number, proliferation
was examined in embryonic Zswim6 mutants. No gross change was found at
E14.5 (Figure 3.20), although an alteration in proliferation that caused a 15%
difference in neuron number could be very difficult to detect. There was no
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increase in the expression of the apoptosis marker cleaved caspase 3 at E14.5,
P0, P21 or in adults (data not shown).
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Figure 3.21. Behavioral defects in Zswim6 null mutants.
(A). Zswim6 KOs achieved significantly lower terminal speeds on the rotarod test
(N=14 WT, 15 KO).
(B). In the open field the KOs had more beam breaks, more rearing events, and
decreased thigmotaxis (N=16 WT, 19 KO).
(C). Force plate analysis showed greater distance traveled, increased hind limb
jumps, decreased low mobility bouts, and increased time in the center (N=9 WT, 7
KO).
(D). In the elevated zero maze there were non-significant trends towards increased
percent time in the open sections and increased average speed for the KOs (N=12
WT, 13 KO).
(E). Amphetamine (2mg/kg; administered at 30 minutes) did not alter motility of
controls (dark blue and purple lines show wild-types treated with amphetamine or
saline, respectively; N=12 WT-amph, 13 KO-amph, 4 WT-saline, 4 KO-saline). In
contrast, 2mg/kg amphetamine significantly increased the motility of the Zswim6
KOs over its moderately elevated baseline. *p<.05, **p<.01, ***p<.001. Error bars
indicate SEM.

To determine whether striatal volume loss could also be secondary to defective
dendritic arborization in the Zswim6 mutants, adults were subjected to Golgi-Cox
staining (Figure 3.18). Indeed, there was a significant reduction in total dendritic
length and in the number of dendrites per cell. Spine density was also
significantly decreased, suggesting a loss of synaptic input.
To determine whether this effect is striatal specific, we also examined the
neocortex. Neocortical volume was less affected than that of the striatum in
Zswim6 mutants, but was significantly reduced by about 7% (Figure 3.16).
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Analysis of layer 3 pyramidal neurons of medial frontal cortex revealed reduced
total length of the basilar dendrites in the mutants, whereas the apical dendrites
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Figure 3.22. Brainstem auditory evoked response testing on Zswim6 knockout
mice.
(A). Zswim6 knockout (KO) mice have a dramatically reduced startle response to
increasing auditory stimulation.
(B). Electrophysiological tracings of brainstem responses to a 16 kHz pure tone
played at three different sound intensities shows that one Zswim6 knockout has no
response, indicating a potential for deafness.
(C). KO mice have on average normal auditory thresholds at different frequencies.
(D). Electrophysiological brainstem responses to a 16 kHz pure tone for three WT
and three KO mice.

were not affected (Figure 3.19). Interestingly, layer 3 pyramidal neurons in the
somatomotor region were unchanged in the mutants, suggesting that the deficits
may be most pronounced in areas such as the medial frontal cortex and striatum
most associated with neuropathological findings in schizophrenia. How Zswim6
loss of function results in these abnormalities is unclear although, since the
targeting construct included the capacity to generate conditional mutants, future
studies will be able to evaluate whether, for example, striatal or cortical specific
loss of this putative chromatin regulator alters gene expression and corticostriatal circuitry during development.
Based on the findings of striatal defects Zswim6 mice were subjected to a battery
of behavioral tests. Remarkably, they showed defects in the rotarod, increased
rearing and hind limb jumping behavior, and hyperactivity in the open field which
was further increased by a dose of amphetamine that did not alter the activity of
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controls (Figure 3.21). These alterations are consistent with defects in striatal
functioning.
In sum, we have generated null mutant mice for the schizophrenia-associated
gene Zswim6. While our analysis is not exhaustive, loss of Zswim6 results in
striatal and cortical abnormalities that are consistent with schizophreniaassociated endophenotypes, including spine density reduction in frontal cortex
and hypersensitivity to amphetamine. We thus conclude that this appears to be a
useful model for studying the function of a schizophrenia-associated gene at the
molecular, functional circuitry, and behavioral levels.
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CHAPTER 4
Ongoing Studies & Future Directions

4.1 Overview
The work in this dissertation largely seeks to identify novel molecular-genetic
pathways that regulate the production of distinct neuronal subtypes from within
the embryonic subpallium. We harnessed information gleamed from studying the
development of cortical interneurons in vivo to enhance the production of PV
cortical interneurons from embryonic stem cells in vitro. In an effort to identify
new genes that control interneurongenesis, specifically within the SVZ, we
inadvertently discovered novel genetic regulators of striatal ChAT interneurons
and MSN. With an enhanced ability to produce PV cortical interneurons, we can
now begin to explore with greater precision the pathways that regulate PV vs
SST cortical interneuron development, as well as use enriched populations of
cortical interneuron subtypes for cell-based transplantation assays. In addition,
we also provide evidence for the role of Zswim6, and to a lesser extent Zswim5,
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in the development and function of the telencephalon. As a significant
schizophrenia candidate gene, insight into Zswim6 function will hopefully take us
closer to understanding the biological pathways that are affected in different
neuropsychiatric disease states. With rapidly evolving technologies that enable
quicker and higher resolution genome editing, genetic sequencing, and
epigenetic profiling on multiple scales, combined with greater access to large
genetic patient datasets, we are now poised to answer some of the most
challenging questions in neuroscience. The following chapter will discuss our
ongoing efforts to build upon the work presented in this thesis, as well as
describe future directions that these projects could move in.
4.2 RNA and Epigenetic Profiling of mESC-Derived Fate Committed Cortical
Interneurons
Evidence from fate mapping studies has shown that interneuron subtypes have
distinct spatiotemporal origins. Knowledge of the transcriptional programs that
direct interneurongenesis will likely reveal how different interneuron fates are
determined. In addition, many studies have demonstrated that neuronal fate
determination occurs before or around the time of cell cycle exit, often based on
the functions of transcription factors expressed selectively within the proliferative
zones. However, cortical interneurons undergo an extended period of migration
prior to their maturation into interneurons with subgroup or subtype-defining
features. In mouse, migration from the MGE, LGE, and CGE into the overlying
cortex takes approximately one week. A highly similar migration occurs in
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humans328,329, where it may require 4 to 8 weeks. During this time, interneuron
morphology and migratory behavior is indistinguishable across interneuron
subgroups. However, the mechanisms by which distinct neuronal fates are
maintained during the migration period, when they may no longer express the
genes initially required for their fate determination, is largely unknown. A major
advance that our current mESC study makes is the ability to strongly enrich for
either PV or SST subtypes, using a single cell line and without the need for
forced gene expression. We are thus in a unique position to profile early postmitotic, differentially fate-committed cortical interneurons in vitro.
We hypothesize that the mechanism by which interneuron fate potential is
maintained throughout the extended migration period depends upon either a
RNA transcript(s) and/or epigenetic landscape(s). In order to identify these
molecular memory traces, we have begun collecting differentially fated
Lhx6:GFP+ cortical interneuron precursors for RNA-seq and ATAC-seq. RNA-seq
will allow us to identify RNA transcripts that are differentially expressed between
PV and SST-fated populations. ATAC-seq will enable us to identify regions of
open and closed chromatin that correlate with expressed transcripts, enhancers,
and, potentially, regions of the genome that are poised to be expressed (e.g.
open) but remain inactive until migration has ended. For the latter possibility, our
hypothesis is that genes driving subgroup-selective differentiation after the
migratory phase will be “poised” for transcription in newly born Lhx6:GFP + cells
from one subgroup and “closed” for transcription in the other. Ultimately, this
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would be combined with chromatin signature analysis by ChIP-seq to compare
“poised” and repressed loci across the PV- and SST-fated cells. A similar
approach has recently been used to correlate cell type-specific transcriptomes
with an atlas of open chromatin to identify novel genes and transcriptional
regulatory elements that confer cell-type identity, while simultaneously retaining
cell-fate plasticity, in purified populations of human pancreatic α- and β-cells330.
To test whether this approach will be useful in identifying novel transcripts and/or
epigenetic landscapes specific to PV and SST subtypes, we have collected PVand SST-fated cells for this purpose. To enrich for SST-subtypes, we used a
modified version of our previously published protocol280. We grew cells under
high Shh conditions from DD8-12 and then collected Lhx6:GFP-only expressing
cells on DD12. During cell sorting, 3 x 125,000 cells were collected for RNA-seq,
followed by 4 x 50,000 cells for ATAC-seq. To confirm that the collected cells are
enriched to become SST subtypes, we sorted additional cells for transplantation
into neonatal neocortex. Only those differentiations that produce the intended
ratio (i.e. 6:1 SST:PV for the SST-enriched protocol and greater than 5:1 PV:SST
for the PV-enriched protocol) will be used for downstream analyses. To enrich for
PV-subtypes, we grew cells under low Shh conditions (SAG from DD8-10,
combined with aPKCi from DD8-16) and collected Lhx6:GFP::Nkx2.1:mCherry
double-positive cells on DD16. We collected cells 5 days later than the PVprotocol described in this dissertation in an attempt to further enrich for PV, since
previous work from our lab has shown that increased time in culture enhances
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the genesis of PV subtypes at the expense of SST subtypes. Upon confirmation
of cell fate, members of Zhaolan Zhou’s lab at the University of Pennsylvania will
proceed with preparing DNA and RNA libraries for ATAC-seq and RNA-seq,
respectively, from the sorted populations. Bioinformatic analyses will then be
used to identify transcripts enriched in either the SST or PV-fate cells. Gene
expression analyses including qPCR, immunohistochemistry, and in situ
hybridization will be used to confirm the expression of any candidate genes
identified in this analysis. In parallel with the RNA-seq data, bioinformatic
analyses of the ATAC-seq data will be used to identify regions of open and
closed chromatin. We anticipate that a large number of genes will be coexpressed in both populations and that these will correlate with regions of open
chromatin. However, we also anticipate finding regions of chromatin that are
open in one population but closed in the other, and then correlate this with RNAseq data to identify regions that are poised for transcription but not yet active. We
will then use previously published gene expression datasets of mature PV and
SST populations to see if any poised regions (e.g. closed in one population and
open in the other but not transcribed) become active upon terminal
differentiation. Follow-up analyses would show that poised regions identified on
the basis of RNA-seq and ATAC-seq data are defined by the simultaneous
presence of histone modifications associated with both gene activation and
repression (e.g. H3K4me3 and H3K27me3, respectively)331. Meanwhile, the
same regions of chromatin in the other cell population should be defined by the
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presence of histone modifications associated with gene repression. Finally, gene
and chromatin loci “hits” will be tested functionally in mESC differentiations.
Candidate genes will be knocked down via RNAi or CRISPR-Cas9 mediated
mechanisms to determine their influence on cell fate. Meanwhile, candidate
genomic loci will be activated or repressed using CRISPR-Cas9 mediated gene
activation and/or repression.
4.3 Notch Inhibition to Enhance the Generation of SST-subtypes from
Embryonic Stem Cells
As mentioned earlier, a previous study from our lab used electroporation of a
dominant-negative version of the Mastermind-like-1 protein (dnMAML) to block
notch signaling within apical MGE progenitors and force them out of the cellcycle133. The result was a remarkable enhancement of SST-interneurongenesis
at the expense of PV subtypes. In parallel with our current effort to enhance SVZlike neurogenesis in vitro via aPKC inhibition, we are using notch inhibition in our
stem cell system to promote early cell cycle exit, and by extension, SST-fate
specification. To do so, we are using the well-established γ-secretase inhibitor
DAPT to block notch signaling in vitro332,333. Γ-secretase is required to cleave the
notch intracellular domain (NICD), which translocates to the nucleus to activate
notch effector genes. When γ-secretase is inhibited, NICD is prevented from
entering the nucleus and notch signaling is effectively eliminated. We
hypothesize that interneuron progenitors forced to undergo cell-cycle exit will
preferentially produce SST-fated interneurons at the expense of PV subtypes
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secondary to intermediate progenitor cell depletion. To this end, we added DAPT
to our stem cell cultures from DD10-12 and then collected Lhx6:GFP+ and
Lhx6:GFP::Nkx2.1:mCherry double-positive cells on DD12 for transplantation. Of
note, time lapse video microscopy shows that GFP is expressed at cell cycle exit,
when Nkx2.1 is downregulated in cortical interneurons, but that there is a brief
window when mCherry perdures, enabling the isolation of newly born, postmitotic GFP+/mCherry+ cells269. In agreement with our in vivo findings, we find
that the addition of DAPT (10μM) to our mESC cultures from DD10-12 causes a
~2 fold increase in the fraction of GFP+ and GFP+/mCherry+ cells together with a
27% decrease in the fraction of mCherry-only expressing cells (Figure 4.1).
These results are consistent with a dramatic increase in cell cycle exit. These
experiments are currently ongoing.
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Figure 4.1. DAPT forces progenitors to exit the cell cycle.
We added the notch inhibitor DAPT from differentiation days 10-12 during directed
differentiations of our Nkx2.1:mCherry::Lhx6:GFP dual reporter mouse embryonic
stem cell line and measured the percentage of mCherry+ (Nkx2.1+ progenitors),
mCherry+/GFP+ (early post-mitotic precursors), and GFP+ (later post-mitotic
precursors) cells via FACS. DAPT causes a ~ two-fold increase in the percentage of
mCherry+/GFP+ and GFP+ cells and a corresponding ~25% reduction in the
percentage of mCherry+ progenitors.

4.4 Embryonic Stem Cell-Derived Interneuron Based Therapy for Epilepsy
Now armed with the ability to generate enriched populations of PV expressing
interneurons from mESCs, we are exploring the potential for using mESC derived
cortical interneuron transplantation as a cell based therapy for Dravet syndrome.
Dravet syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI),
is a malignant seizure disorder in which affected children develop medication
resistant seizures, developmental delay, and severe to profound intellectual
impairment. About 10-15% of children with Dravet syndrome will eventually die
from status epilepticus or sudden unexpected death in epilepsy (SUDEP).
Approximately 80% of SMEI cases are due to mutations in the gene SCN1A334.
Importantly, several studies have shown that loss of SCN1A causes impaired
action potential firing of inhibitory interneurons with little to no effect on the
activity of excitatory neurons. This suggests that interneuron dysfunction,
particularly of PV subtypes, is the cause of seizures in Dravet syndrome185,186.
Based on these studies, we hypothesize that transplantation of mESC-derived
PV interneuron precursors into neonatal cortex and hippocampus will mitigate the
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development of epilepsy in transgenic mice engineered to harbor a mutation in
SCN1A (Scn1aRH) that is associated with cases of Dravet syndrome.
Furthermore, we hypothesize that transplants enriched for PV interneurons will
more efficiently modify epilepsy in Scn1aRH mouse pups than either mixed
transplants or those enriched for SST-subtypes. To this end, we will perform
stereotaxic injections into five sites bilaterally (frontal, parietal, and occipital
neocortex, and dorsal and ventral hippocampus) at P0 and P1. We will inject four
different treatment conditions: (1) PV-enriched interneuron cell transplants; (2)
SST-enriched interneuron cell transplants; (3) freeze-killed interneuron cell
transplants; and (4) untransplanted negative controls. Based on our previous
studies, we anticipate that mESC-derived interneurons will occupy appropriate
cell type-specific niches and integrate functionally into host cerebral cortical brain
circuits, thereby augmenting cortical inhibition. Approximately four weeks posttransplantation, intracranial EEG electrodes will be surgically implanted into
Scn1aRH mice and controls. In conjunction with video monitoring, EEG data from
P28-P35 will be analyzed to determine whether interneuron cell transplants delay
the onset, frequency, or duration of seizure activity in Scn1aRH mice, as well as
quantify the rate of epilepsy-associated cell death. We are also developing
several additional variants of our Nkx2.1:mCherry::Lhx6:GFP line that will enable
us to pharmacologically or optogenetically control the activity of transplanted
cells. By using the PiggyBac transposon system, we can insert stable transgenes
into our dual reporter mESC line. We have begun generating a dual reporter line
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that expresses the inhibitory DREADD (designer receptor exclusively activated
by designer drugs;335,336), hM4DGi, which enables us to “turn off” transplanted
interneurons in the intact animal en masse to allow for confirmation of continued
presence of the cell graft as required for seizure suppression. We have also
started the generation of another line engineered to express the red-shifted
channelrhodopsin ChrimsonR337, which will allow “on-demand” recruitment of
transplanted interneurons to terminate ongoing seizures in Scn1aRH mice using
a closed-loop stimulation system coupled to a wireless EEG transmitter. To date,
we have done two rounds of PV-enriched interneuron cell transplants into
Scn1aRH mice and controls. For reasons that we do not fully understand, our
first series of injections were largely unsuccessful in that we failed to achieve
large numbers of cell engraftment in the cortex. We injected upwards of 400,000
cells into each animal over the course of two days, and upon immunohistological
examination of the transplanted tissue found fewer than 1000 cells within the
cortex, with many cells engrafted into the amygdala and ventricular walls.
Reasons for the poor outcome may be related to the number of cells we injected
(too many cells may elicit an immunogenic response leading to decreased
survival), the age of the cells we injected (cells taken from later stage cultures
have reduced survival relative to progenitors isolated from early stage cultures),
incorrect targeting (differences in cortical thickness between mouse strains may
have caused our injections to enter the ventricles rather than the cortex), or the
volume of solution that we injected. For our second experiment we injected at
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only one time point (P1), bilaterally into the cortex with 100,000 cells per injection
site. We are currently awaiting results from this experiment. If successful, this
project will help us determine whether mESC-derived interneuron transplants
have the potential to help human patients with SCN1A mutations. In addition, we
will hopefully gain insight into whether PV-enriched, SST-enriched, or mixed cell
transplants are more or less efficacious in mitigating seizure activity.
4.5 Ongoing Studies and Future Directions for Understanding Zswim6
Function
The data presented in this thesis suggest that Zswim6 plays an important role in
brain development and function. However, there are many questions that remain
to be addressed. As a schizophrenia candidate gene, it is important to determine
whether Zswim6 acts predominately during embryonic development to regulate
the production of forebrain derivatives or during postnatal periods to regulate the
function of MSN and their associated circuits (or both). Although schizophrenia
typically manifests in the late teens and early 20’s, it is thought to have a strong
developmental component that affects the formation of essential brain circuits.
Zswim6 is expressed at high levels in the developing striatum and limbic regions,
including the cortex. Postnatally, its expression becomes restricted to the
striatum. Does Zswim6 function in progenitors to regulate the production of
different neuronal subtypes? Or does it act as a transcriptional regulator in
mature MSN to fine tune gene expression? The changes in morphology and
spine density that we found on adult MSN and frontal cortex pyramidal neurons
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begs the question as to whether those changes are also present during
adolescence. If not, then this supports a predominantly later occurring phenotype
that more closely mimics the biological changes that occur in the context of
schizophrenia. We are currently measuring striatal volume and analyzing
MSN/frontal cortex neuronal morphology on P21 mutants and controls. Another
way we are addressing the time frame and neuronal circuits that Zswim6
predominantly functions in is by breeding our Zswim6 conditional line to several
cre-recombinase expressing lines. These include the DRD1-cre and A2a-cre
lines, which perturb Zswim6 expression in direct and indirect pathway MSN,
respectively. These lines will not only enable us to determine whether loss of
Zswim6 function in post-mitotic MSN is sufficient to recapitulate the behavioral
changes found in our Zswim6 constitutive knockout, but which striatal
subdomains are most important for Zswim6 function. Such an approach was
recently used to understand the synaptic basis of repetitive behaviors observed
in mice harboring mutations in the autism-associated gene neuroligin-3 (NL3)338.
Despite NL3 being expressed throughout the brain, the authors showed that
conditional loss of NL3 within D1-expressing MSN of the nucleus accumbens
was sufficient to recapitulate the repetitive motor routines observed in NL3
mutant mice. On the contrary, loss of NL3 within D2-expressing MSN was
insufficient to induce the behavioral phenotype 338. If we discover that loss of
Zswim6 within either of these circuits is capable of recapitulating our behavioral
phenotypes, then we can further dissect which striatal subdomains are involved
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through the use of adenoviral injections that either rescue or knockdown Zswim6
expression. For example, if we find that Zswim6 knockdown within D1-expressing
MSN is capable of recapitulating our behavioral findings, then we can cross our
Zswim6 constitutive knockout to the DRD1-cre line and inject an adenovirus that
expresses Zswim6 in a cre-dependent fashion into different striatal subdomains
to rescue the phenotype. Alternatively, we can inject a cre-recombinase
expressing adenovirus into different striatal subdomains of Zswim6 Fl/Fl mice to
determine which regions are capable of recapitulating the phenotype. We have
also started to breed our Zswim6 constitutive knockout to DRD1-tomato and
DRD2-EGFP lines, which allow for the unambiguous identification of all major
striatal cell types. We intend to use these lines to do whole cell voltage clamp
recordings of MSN to explore how loss of Zswim6 function affects their excitatory
and inhibitory synaptic parameters, as well as potential alterations in synaptic
plasticity. Using these same lines, we can also FACS isolate mature DRD1- and
DRD2-expressing MSN for gene profiling. If Zswim6 functions as a chromatin
modifier, then we would expect to find changes in gene expression that correlate
with changes in chromatin accessibility. Given that the striatum plays important
roles in decision-making and reward processing, we hypothesize that loss of
Zswim6 will cause additional phenotypes in the initiation or persistence of goaldirected actions, which are particularly affected in schizophrenia339,340. To test
this, Zswim6 mutant mice will be subjected to an operant choice paradigm that
enables us to determine whether Zswim6 mutants exhibit deficits in their ability to
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use reinforcing stimuli (e.g. rewards) to reliably reinforce future behavior.

In

addition to behavioral experiments, it would be interesting to determine how
Zswim6 functions on a biochemical level. To start, one might identify Zswim6
binding partners using mass spectrometry. Previous studies have found that
Zswim6 is expressed in HEK293 cells294,301. Thus, while its binding partners in
HEK293 cells may differ from those in the brain, we can still learn a great deal
about the type of complexes it is capable of forming. Ultimately, we eventually
want to determine whether Zswim6 function in mice is similar to its function in
human. To do so, one might use CRISPR-Cas9 to inactivate Zswim6 in human
stem cells, then differentiate these cells into distinct neuronal subtypes, including
MSN, for which there are established differentiation protocols341,342.
At present, a shortcoming of this study is our inability to explain the reduction in
MSN number that we observe in adult Zswim6 knockout mice. Although we did
not find a decrease in proliferation at E14.5, this was the only age we analyzed.
Measuring proliferation at other time points may reveal a subtle proliferation
defect. Along the same vein, we only looked for apoptosis at P0, P21, and in
adult. It is possible that MSN undergo apoptosis during a very narrow time
window that we have missed in our analysis. It will be important to quantify MSN
number using the aforementioned cre-recombinase lines to determine whether
loss of MSN is due to a lack of production, apoptosis, or a combination of the
two, as well to determine whether the decreased number of MSN contributes
significantly the phenotypes we observe.
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Another potential shortcoming of this study is the possibility of inner ear defects
in Zswim6 mutant mice, since inner ear dysfunction has been shown to cause
hyperactivity by inducing specific molecular changes in the striatum 343. However,
it is unclear whether hyperactivity due to inner ear defects is secondary to
hearing loss, vestibular dysfunction, or a combination of the two. Zswim6 mutant
mice do not exhibit circling behavior, a hallmark of vestibular dysfunction,
suggesting that if they have inner ear dysmorphogenesis, it primarily affects their
hearing ability. Zswim6 is expressed at low levels in many developing brain
areas related to hearing, including the cochlear membrane, spiral ganglion cells,
cochlear nucleus, thalamus, and auditory cortex (D.J. Epstein, V.E. Abraira,
personal communication)293,325. Despite the widespread expression of Zswim6,
its relative significance in these regions, if any, remains to be determined. For
future studies, it will be important to determine whether Zswim6 mutant mice are
indeed deaf. We will need to perform brainstem auditory evoked response testing
(BAER) on a large (N=12-15) cohort of mice. In addition, we can also do BAER
testing using various cre-recombinase expressing lines (e.g. nestin-cre) to
perturb Zswim6 function in particular circuits. Such an analysis would help
determine whether Zswim6 causes neural/sensorineural or conductive hearing
loss, if at all.
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CHAPTER 5
Materials and Methods

5.1 Materials and Methods for mESC Studies
Mouse Embryonic Stem Cell Culture.
Mouse ES cells (the JQ27 mESC-Nkx2.1::mCherry:Lhx6::GFP line) were grown
on mouse embryonic fibroblasts (MEF CF-1 MITC7M, GSC-6101M, Global Stem)
in standard mESC medium (knock-out DMEM (Invitrogen), 15% FBS (InvitrogenThermo Fisher Scientific), supplemented with L-glutamine, MEM nonessential
amino acids, β-mercaptoethanol, and LIF (1.4ul/mL [107 U/mL] ESG1107,
Millipore). To eliminate MEFs, mESCs were replated on a 0.1% gelatin coated
plate for 1-2 days prior to differentiation.
Telencephalic mESC Differentiation.
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For neural induction, mESCs were harvested and floated on non-tissue culture
treated plates in a 1:1 mixture of KSR (10828-028, Invitrogen) and N2 media
(DMEM:F12, 11330, Invitrogen, with N2 07156, Stemgent) supplemented with
LDN-193189 (250nM, 04-0074, Stemgent) and XAV939 (10μM 04-0046,
Stemgent) as described previously (Maroof et al 2010 & Watanabe et al., 2005).
At differentiation day 3 (DD3), embryoid bodies (EBs) were enzymatically
dissociated using Accutase (A1110501, Invitrogen) and single cells were replated
onto poly-L-Lysine (P6282, Sigma)- and laminin (L2020, Sigma)-coated plates at
(37,500 cells/cm2) in the same media supplemented with Y-27632 (10nM, 1254,
Tocris). For the dorsal/ventral (D/V) patterning, cells were treated with KSR/N2
media supplemented with FGF-2 (10 ng/ml, DD5–9, 233-FB, R&D Systems),
IGF1 (20 ng/ml, day 5–9, 291-G1-200/CF, R&D Systems) from DD5 to DD8. At
DD8, cells were replated on PLL- and LN-coated plates at 200,000 cells/cm2 and
treated with KSR/N2 media supplemented with SAG (30 nM, EMD Biosciences,
Inc.) and protein kinase C ζ Inhibitor (PKCi) (2 µM, EMD Biosciences, Inc.). Cells
were cultured until DD11 and then processed for FACS or IHC. For DAPT
experiments, DAPT was added to a final concentration of 10μM from DD10-12.
Cells were then sorted on DD12 and transplanted.
Cell Sorting.
Samples at DD11 or later were treated with Accutase (Invitrogen) for 15 min,
centrifuged at 900 rpm for 5 min, and resuspended in Hiberante E (Invitrogen)
supplemented with B27, glutamax, and Y-27632 (10nM, 1254, Tocris). After
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filtration twice through a 40μm filter, samples were kept on ice until FACS (Aria II,
BD Biosciences) and analyzed using FACS Diva software (Version 6.1.3).
Cortical Transplantation.
Transplantation of neural precursors into the somatosensory cortex of coolinganesthetized neonatal pups was conducted as described previously (Maroof et al
2010 and Wonders et al., 2008). After sorting for Nkx2.1::mCherry progenitors,
cells were resuspended in neurobasal medium (NBM) supplemented with Y27632 (10 nM), glutamax, and B27 at 30,000 ~ 50,000 cells/µL. About 6 µL of
cell suspension medium was bilaterally injected into the somatosensory cortex at
the following coordinates from bregma (2.0 mm anterior, 2.5 mm lateral, 1.0 mm
deep), targeting cortical layers 3–6 of CD1 pups at P0-2. Mice were perfused
and analyzed 30 days post-transplant. Care of animals was in accordance with
institutional guidelines at The Children’s Hospital of Philadelphia.
Immunohistochemistry.
Samples were fixed in 4% paraformaldehyde in PBS and blocked in 5% BSA in
0.1% PBST.

For antibodies requiring the use of antigen retrieval (mouse-

Nkx2.1), samples were pretreated with 1mM ETDA in PBS for 5 min at 65°C.
After washing, samples were incubated in primary antibodies, followed by
secondary antibodies with DAPI for nuclear staining. Primary antibodies used
were chicken anti-GFP (Abcam, ab13970; 1:1000), rabbit-Nkx2.1 (1:1000,
Abcam ab76013), mouse anti-Nkx2.1 (Abcam, ab76013; 1:200), rabbit anti-PV
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(Swant, PV-25; 1:2000), rat anti-SST (Millipore, 14224; 1:200), rabbit anti-GABA
(Sigma-Aldrich, A2052; 1:1000), rabbit anti-Sox6 (Abcam, ab30455; 1:2000),
rabbit anti-cyclinD2 (Santa Cruz, M-20, 1:5000), rabbit anti-Ki-67 (Thermo, RB9043, 1:200), and rat anti-RFP antibody (Chromtek, 5F8; 1:400). Secondary
antibodies were conjugated to Alexa fluorophores (488, 568 or 680, Invitrogen).
EdU signals were detected with the Click-iT EdU Alexa Fluor 647 imaging kit
(Invitrogen, Carlsbad, CA, USA).
In Vivo Fate Quantification.
30 days post-transplantation, mice were perfused and fixed with 4%
paraformaldehyde in PBS. Fixed brains were sectioned in the coronal plane at
50μm on a vibrating microtome (Leica). To identify the fate of the transplanted
cells, sections including somatosensory cortex, rostral to the hippocampal
commissure and caudal to the genu of the corpus collosum, were incubated with
the aforementioned antibodies. Generally, 12-15 sections were evaluated per
marker. Transplanted animals were excluded if there were fewer than 25 total
GFP+ cells present, and only GFP+ cells engrafted in cortical layers 2-6 were
included in fate analysis. Each condition was repeated on 4 separate occasions,
with a minimum of two transplanted mice per condition. Therefore, a statistical n
represents counts from multiple transplants of one differentiation experiment.
Statistical significance was determined using a two-tailed Student’s t-test.
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Live Imaging Analysis.
At DD8, cells were replated on PLL- and LN-coated chamber slides (Nunc LabTek II Chambered Coverglass #1.5 Borosilicate) at a density of 200,000
cells/cm2. Time-lapse images were acquired every 15 minutes over the course of
48 hours with an Olympus Fluoview (FV10i) confocal microscope at 37°C, 5%
CO2 at 10x magnification. T-stacks were compiled in ImageJ with GFP and
mCherry channels pseudocolored green and red, respectively. Only cells that
could be visualized throughout the entire imaging session were included in the
daughter cell analysis. The percentage of daughter divisions was calculated as
follows: % daughter division = # daughter divisions/(mCherry parent division +
daughter division). At least 20 divisions were counted for each condition across
five independent experiments. Statistical significance was determined using a
two-tailed Student’s t-test.
Cell Counting.
For CD2, EdU, and Ki-67 co-expression analyses, multichannel stacks were
generated in ImageJ. For each experiment, at least 500 clearly labeled Nkx2.1 or
RFP cells were marked using the ImageJ cell counter plugin. After marking,
these cells were examined for CD2, EdU, or Ki-67 co-expression by alternating
between channels. Each condition was repeated on at least 3 separate
occasions. Statistical significance was determined using a two-tailed Student’s ttest.
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5.2 Materials and Methods for Zswim5 and Zswim6 Studies
Mouse Lines
This study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Institutional Animal Care and Use
Committee at The Children’s Hospital of Philadelphia (Protocol Number: 2012-41004). ABR measurements were performed under anesthesia (ketamine
(100mg/kg)/xylazine (10mg/kg) cocktail). Adult mice were euthanized by
isoflurane overdose, followed by cervical dislocation. All efforts were made to
minimize suffering. Behavioral experiments were performed during the first 3
hours of the light phase (7:00-11:00am) and animals were allowed to acclimate
to the procedure room for at least 15 minutes before beginning experiments.
Primers used for genotyping animals and for generating in situ hybridization
probes are summarized in (Table 5.1).
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Table 5.1. List of primers used in this study.
Mouse lines
Zswim6

Primer Name
Z6-3G-FWD
Z6-3G-REV
DelExonP1-F
DelExonP1-R
3'UTR_ISH-F
3'UTR_ISH-R
Exon3-5_F
Exon3-5_R
Zswim5
Z5-2G-FWD
Z5-2G-REV
DelExonP1-F
DelExonP1-R
3'UTR_ISH_F
3'UTR_ISH_R
Exon2-4_F
Exon2-4_R
Exon5-8_F
Exon5-8_R
Nkx2.1-Cre
P1
P2
KOMP-Zswim5 CSD-F
Exon2REV
Lar3

Sequence
Floxed Allele WT Allele KO or Cre Allele
catggaagtacttgggtccga
893
716
~300
ttctccatgtgggaaaactagaaag
893
716
~300
TGGCCATCAGCTTTGATCGT
328
no band
TCGTCAATACTAGCACCCGC
328
no band
tacattacgcctttgcagtg
524
ACATGAGTGAAGAAGTACAACC
524
GCAAGCCAGAGCAGGTCAAAC
478
TCATCCCAGAGCTGCCTATACTTG
478
atgccgtggaatgtagaacagat
1031
846
~380
ctgatttcgaggctgggctta
1031
846
~380
CGGCTGTGGGAATAAGGACA
369
no band
CCCCCAATGATACCGAGACC
369
no band
TCAGGACAAGGACTCTGAAAC
550
ATCTTCAGGCCACAGTTTCTG
550
GAGCCAGCAGTGACTTACAAGG
504
cctggctccattagaatctctc
504
GGATGGAAACTATGGGCATGAG
484
CAAAGTGAGAAACAGGCAGCCAA
484
CCACAGGCACCCCACAAAAATG
no band
666
GCCTGGCGATCCCTGAACAT
no band
666
tgtagaagatgctggatgaattgtgc
~420
~270
GTTGATTTCTGAGTTGGAGGAC
~420
~270
cacaacgggttcttctgttaqgtcc
~420
~270

Purpose
Genotyping
Genotyping
Confirm KO
Confirm KO
ISH
ISH
ISH
ISH
Genotyping
Genotyping
Confirm KO
Confirm KO
ISH
ISH
ISH
ISH
ISH
ISH
Genotyping
Genotyping
Genotyping
Genotyping
Genotyping

We worked with Ingenious Targeting Laboratories (Ronkonkoma, New York,
USA) to make the Zswim5 and Zswim6 conditional knockouts. For Zswim6, a
13.75-kb Zswim6 genomic fragment was subcloned from a C57BL/6 BAC clone
to construct the targeting vector using homologous recombination. A FRT-LoxPNeo-FRT-LoxP cassette was inserted downstream of exon 4 and the third single
LoxP site was inserted upstream of exon 4. The region flanked by the second
and third LoxP sites is approximately 569bp. Exon 4 encodes amino acids 337386 and its deletion causes an early stop. The short homology arm extends
2.1kb to the 3’ end of the FRT-LoxP-Neo-FRT-LoxP cassette, whereas the long
homology arm extends 5.1kb from the 5’ side of the third loxP site. The linearized
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targeting vector was then electroporated into iTL BA1(C57BL/6X129/SvEv)
hybrid embryonic stem cells.
A 16.64kb genomic fragment of the Zswim5 gene was used to construct the
targeting vector. A FRT-LoxP-Neo-FRT-LoxP cassette was inserted downstream
of exon 3 and the third single LoxP site was inserted upstream of exon 3. The
first and second LoxP sites thus flank a 620bp genomic region that includes exon
3. Exon 3 encodes amino acids 321-370 and its deletion causes an early stop.
The short homology arm extended 3.6kb to the first LoxP site and the long
homology arm extended 6.4kb downstream of the LoxP-Neo-LoxP cassette.
Targeted embryonic stem cells were microinjected into C57BL/6 blastocysts.
Resulting chimeras with a high percentage agouti coat color were mated to
C57BL/6 FLP mice to remove the Neo cassette. Heterozygous mice confirmed
for somatic neo deletion were then bred to wild type C57 mice to remove the FLP
transgene. To generate germline null alleles, Zswim5+/F and Zswim6+/F mice were
bred to CMV-cre mice (The Jackson Laboratory Stock NO: 006054) to generate
Zswim5+/- and Zswim6+/- animals.
Tissue Preparation for Immunohistochemistry
Following

euthanasia

with

isoflurane,

mice

were

perfused

with

4%

paraformaldehyde (PFA) in PBS and post-fixed in 4% PFA overnight. Brains
were then embedded in 4% low-melting-point agarose, cut in 50µm sections with
a vibrating microtome (Leica), and stored in antifreeze solution (30% ethylene
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glycol and 30% glycerol in 1x PBS) at -20̊C until processing. Embryonic samples
for in situ RNA hybridization and immunohistochemistry were processed
identically (see section Tissue Preparation for In Situ RNA Hybridization below)
Immunohistochemistry
Brain sections were pre-incubated for one hour in blocking buffer (5% bovine
serum albumin with 0.1% Triton-X-100). Sections were then incubated overnight
at 4̊C with the following primary antibodies: rabbit anti-PV (Swant, PV-25;
1:2000), rat anti-SST (Millipore, 14224; 1:200), rat anti-CTIP2(Abcam, ab18465,
1:500), goat anti-ChAT (Chemicon, ab144P, 1:200), rabbit anti-phospho-Histone
H3 (Millipore, 06-570, 1:400), rabbit anti-cyclinD2 (Santa Cruz, M-20, 1:5000),
rabbit anti-DARPP32 (Abcam, ab40801, 1:1000), mouse anti-TH (Millipore,
MAB318, 1:200). Secondary antibodies were conjugated to Alexa fluorophores
(488, 568 or 680, Invitrogen). DAPI (300nM) was applied concurrently with
secondary antibodies to label cell nuclei. EdU signals were detected with the
Click-iT EdU Alexa Fluor 647 imaging kit (Invitrogen, Carlsbad, CA, USA).
Cell Counting
Stereological analysis for CTIP2 was conducted on a Nikon E600 microscope
equipped

with

a

motorized

stage

and

Stereoinvestigator

software

(MicroBrightField). CTIP2 cell counts were obtained using the Optical
Fractionator Probe and systematic random sampling at 40x magnification.
Optical dissector frame and counting grid sizes of 60µm x 60µm and 700µm x
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700µm, respectively, were used. Striatal contours were delineated as described
by Franklin and Paxinos (2008). Starting from the genu of the corpus callosum,
every 5th section was evaluated for a total of 6 sections.
For PV, SST, and ChAT cell counts, 10x montages of entire brain sections were
generated using Stereoinvestigator’s Virtual Tissue module. Starting from the
genu of the corpus callosum, every 5th section was imaged for a total of 6
sections. Images were opened using ImageJ and the striatum was delineated as
described by Franklin and Paxinos (2008). Using the ImageJ cell counter plugin,
striatal interneurons from each brain section were counted and then summated.
Statistical significance was determined using a two-tailed Student’s t-test.
For PH3 and EdU counts, image stacks were opened in ImageJ and three
120µm x 120µm boxes were drawn beginning at the apical surface and
extending outward from LGE along a line that was approximately equidistant
from the pallial-subpallial angle and MGE-LGE sulcus (as shown in Figure 3.20).
Volumetric Analyses and Surface Area
Volumetric

analyses

were

done

using

the

Cavalieri

estimator

on

Stereoinvestigator (MicroBrightField). We used a total of 11, 50µm thick sections
in our analysis, where section 3 of 11 along the rostrocaudal axis corresponded
to the first section in which the genu of the corpus callosum could be identified,
and used every 5th section from that point. Cortical contours were drawn using
the pial surface as the outside boundary and terminated laterally at a point that
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was perpendicular to the midline. For surface area analyses, we took overhead
images of adult brains using a dissection microscope fitted with a digital camera.
Images were then opened in ImageJ and analyzed using the area measure tool.
Statistical significance for volumetric and surface area analyses were determined
using a two-tailed Student’s t-test.
Quantitative PCR (qPCR) Analysis
Following euthanasia with isoflurane, Zswim6 mice were decapitated and their
brains rapidly dissected. Brains were then sectioned at 400µm in ice cold PBS
using a vibrating microtome. Dorsal striatum was carefully dissected and placed
in TRIzol reagent (Invitrogen) for RNA extraction using the PureLink RNA Mini kit
(Invitrogen). cDNA was synthesized using the VILO cDNA synthesis kit
(Invitrogen). qPCR was conducted using Taqman Gene Expression Assays
(Applied Biosystems). Each sample was run in triplicate, along with probes for
GAPDH on the same plate, on a Stratagene MX3005P real-time PCR machine
(La Jolla, CA) following the manufacturer’s recommended protocol. Data were
analyzed using the comparative CT method. Statistical significance was
determined using a two-tailed Student’s t-test.
Golgi-Cox Staining and Neuron Reconstruction
Golgi-Cox staining was performed using the FD Rapid GolgiStain kit (FD
NeuroTechnologies). Brains were incubated in a potassium dichromate solution
for 2 weeks in the dark, then with silver nitrate for another two days before being
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cut into 150µm sections with a vibrating microtome (Leica). Golgi staining was
then performed on slides. Cell bodies and dendrites of striatal MSN and layer 3
cortical pyramidal neurons from each group were traced and analyzed using
Neurolucida (MicroBrightField). Only MSN within the dorsal striatum were traced.
We delineated medial frontal cortex as the region bounded dorsolaterally by
motor cortex extending along the midline from 2.65mm-2.09mm rostral to
Bregma as defined in Franklin and Paxinos (2008). We considered somatomotor
cortex to encompass a 500µm region on either side of the boundary between
primary motor and somatosensory cortices extending from the genu of the
corpus callosum to where the anterior commissure connects at the midline, using
as reference Franklin and Paxinos (2008). Morphological differences were
analyzed using a two-tailed Student’s t-test. For Sholl analyses, a two-way
ANOVA was used to determine significance using Prism 5 (GraphPad).
Β-Galactosidase Staining
Embryos were flash frozen in liquid nitrogen, sectioned at 12µm using a cryostat,
and stored at -80̊C. On the day of staining, the sections were fixed for 5 minutes
in 0.2% glutaraldehyde, 2% formalin, 5mM EGTA and 2mM MgCl2 in 0.1M
phosphate buffer (pH 7.3) for 4 hours. They were then washed three times in
rinse buffer (0.1% sodium deoxycholate, 0.2% IGEPAL, 2mM MgCl2 in 0.1M
phosphate buffer (pH 7.3) and incubated in the dark at 37̊C in staining solution (1
mg/ml Salmon gal (Lab Scientific) and 0.4 mM 5-bromo-4-chloro-3-indolyl
phosphate (TNBT) in rinse solution). The reaction was monitored every 10
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minutes to determine the onset of staining (approximately 1 hour) and then
quenched using 4% PFA in 1x PBS for 10 minutes.
Spine Density Analysis
For

spine

quantification,

dendrites

were

traced

using

Neurolucida

(MicroBrightField) and divided into 10μm segments using a 100x oil-immersion
objective. For each analysis, we counted spines from a minimum of 10 neurons
from each animal. For MSN, we counted spine density at a distance of 60-150μm
from the soma and analyzed a minimum of 40μm from each neuron; both primary
and secondary dendrites were included. A total of 2400μm of dendrite were
analyzed from each group and the reported average is the spine density for each
group between 60-150μm. For layer 3 pyramidal neurons, spine quantification
was done on the basilar dendrites at a distance of 10-110μm from the soma with
a minimum of 50μm analyzed from each neuron. A total of 3000μm of dendrite
was analyzed from each group. Statistical significance was determined using a
one-tailed Student’s t-test, where each data point represented the average
number of spines per 10μm for the dendritic range (e.g. 60-150μm for MSN) that
we analyzed.
Tissue Preparation for In Situ RNA Hybridization
For embryonic samples, embryos were fixed overnight at 4̊C in RNase-free 4%
PFA in 1x PBS. Embryos were then washed two times in 1x PBS and
cryoprotected by immersion through sucrose (15 and 30% sucrose in 1x PBS;
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solutions were changed once embryos had sunk). Afterwards they were
embedded in freezing compound and stored at -80̊C until sectioning. For adult
samples, mice were perfused with 4% PFA in 1x PBS and post-fixed in 4% PFA
overnight. Brains were then embedded in 4% low-melting-point agarose, cut in
50µm sections with a vibrating microtome (Leica), and stored in antifreeze
solution (30% ethylene glycol and 30% glycerol in 1x PBS) at -20̊C until
processing. On the day of in situ hybridization, sections were mounted onto
Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) and allowed to dry at
room temperature for 2 hours before processing.
In Situ RNA Hybridization
We generated cDNA templates for riboprobe synthesis for Zswim5 and Zswim6
by nested PCR incorporation of T7 and Sp6 RNA polymerase promoters using
the primers listed in (Table 5.1). Template cDNA was obtained from E13.5
mouse brain. cDNA plasmids for DRD1 and DRD2 were gifts from Kenneth
Campbell. Following incubation in prehybridization buffer for 2 hours at 60̊C,
sections were incubated with digoxigenin-labeled riboprobes for 16 hours at 58̊C.
After rinsing, sections were incubated with an alkaline phosphatase conjugated
sheep anti-digoxigenin antibody (Roche, 1:2000) in blocking buffer at 4̊C for 16
hours

and

developed

in

nitroblue

tetrazolium/5-bromo-4-chloro-3-indolyl

phosphate solution (7μl/ml in 10% polyvinyl alcohol; Roche) in the dark for 12-48
hours. Fresh developing solution was exchanged every 24 hours. After
developing, material was rinsed, and alkaline phosphatase activity was quenched
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by fixation in 4% PFA containing 0.125% glutaraldehyde. Sections were then
rinsed, cleared in 50% glycerol in 1x PBS, and mounted using aqueous mounting
media.
Brainstem Auditory Evoked Response (BAER)Testing
BAER testing was done in collaboration with Maria Geffen’s lab at the University
of Pennsylvania as described in344.
Rotarod
For high speed rotarod performance testing a five-station Rotarod treadmill (IITC)
was used. Rotarod testing consisted of three trials per day over the course of 4
days. Days 1 and 2 consisted of 4-40rpm trials over a 300 second period with a
constant rate of acceleration. Days 3 and 4 consisted of 8-80rpm trials over a
300 second period. A trial was terminated when a mouse fell off, made one
complete backward revolution while hanging on, or after 300 seconds (maximum
speed, no further acceleration). On day 1, mice were allowed to acclimate to the
rod for 1 minute before beginning the first trial. On each testing day, mice were
left in the room for 15 minutes to acclimate before testing. The machine was
wiped down with 70% ethanol in between each trial. Groups were compared
using the Mann-Whitney U test.
Open Field
Locomotor activity was assessed with the automated Photobeam Activity System
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(San Diego Instruments). After acclimating to the room for 15 minutes, mice were
individually placed in a 16 x 16 inch arena outfitted with photocells to detect
horizontal and rearing activities over the course of 10 minutes. The arena was
cleaned with 70% ethanol in between trials. For amphetamine-sensitivity testing,
mice were placed in the open field arena for 30 minutes before being injected
with either a 2 mg/kg D-amphetamine hemisulfate salt (Sigma) solution prepared
in isotonic saline at a concentration of 0.2 mg/ml or isotonic saline as control.
Immediately after injection, mice were placed back into the arena for an
additional 1 hour. For the 10 min open field sessions, both groups were
compared using a one-tailed Student’s t test (paired). For the amphetaminesensitivity testing, the effect of amphetamine on ambulation was determined
using a two-way mixed regression analysis performed in Stata.
Elevated Zero Maze
Mice were individually placed on a 2.5 inch wide circular track with an external
diameter of 20 inches, raised 24 inches above the floor (San Diego Instruments).
The track had two open and two walled quadrants of equal dimensions. Mice
were placed in the center of a closed quadrant to begin a 5 min trial. A highly
trained scorer, blind to group designation, graded the digitally recorded trials for
time spent in the open quadrants. Mice were scored as within a segment when
all four paws were within that segment. Transitions between quadrants were also
noted as a measure of general locomotor activity. Groups were compared using
a two-tailed Student’s t test (paired).
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Force Plate Actometer
Force-plate actometer assays345,346 were performed using standard approaches.
Each trial was 45 minutes in length.
Co-immunoprecipitation and Western Blot
The coding sequence for Brg1 was subcloned from pMX-Brg1 (Addgene plasmid
#25855) into a plasmid containing 3 sequential HA tags (Addgene plasmid
#12555). Zswim6 was cloned from cDNA obtained from E13.5 embryonic brain
and subcloned into a Myc-tag containing plasmid (Addgene plasmid #19400).
Both plasmids were transfected into HEK293 cells using Lipofectamine 2000
(Invitrogen). 48 hours post-transfection, cells were lysed in a low-stringency
buffer (50mM NaCl, 1mM MgCl2) on ice for 20 min, followed by 4 seconds of
low-power sonication, and then centrifuged for 5 min at max speed at 4̊C.
Supernatants were then incubated with either anti-HA (Thermo Cat #88836) or
anti-Myc magnetic beads (Thermo Cat #88844) for 100 minutes at room
temperature. Beads were then washed two times with lysis buffer followed by
one wash with ddH20. Bound proteins were eluted by heating the beads to 95̊C
in

sample

loading

buffer

containing

DTT.

The

control

indicates

co-

immunoprecipitation with nonreactive, non-antibody tagged magnetic beads
(Thermo Cat #88826). Samples were then run on 4-12% BoltTM Bis-Tris gels
using the BoltTM Mini Gel Tank and transferred onto nitrocellulose membranes
using the iBlot Transfer System. After transfer, blots were allowed to dry for one
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hour before rehydration in 1x TBS. Blots were incubated in Odyssey Blocking
Buffer in TBS for 1 hour then incubated overnight at 4̊C with anti-Myc (Thermo,
MA1-980, 1:1000) or anti-HA (Cell Signaling, #3724, 1:1000) antibodies. The
next day, blots were washed 3 times for 10 minutes in TBS with 0.1% Tween-20
and then incubated with IRDye 800CW secondary antibodies (1:10,000). Blots
were washed 3 times for 10 minutes in TBS with 0.1% Tween-20 and then
imaged using the Li-COR imaging system.
Nuclear-Cytoplasmic Fractionation
Recombinant myc-Zswim5 was expressed in HEK293 cells using Lipofectamine
2000 (Invitrogen). 48 hours post-transfection, HEK293 cells were collected for
nuclear-cytoplasmic fractionation using the NE-PER Nuclear and Cytoplasmic
Extraction Kit (ThermoFisher). Equal amounts of nuclear and cytoplasmic
fractions were then run on western blot using the aforementioned protocol.
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